JPH09224665A - Beta-fructofuranosidase, production and use thereof - Google Patents
Beta-fructofuranosidase, production and use thereofInfo
- Publication number
- JPH09224665A JPH09224665A JP8353780A JP35378096A JPH09224665A JP H09224665 A JPH09224665 A JP H09224665A JP 8353780 A JP8353780 A JP 8353780A JP 35378096 A JP35378096 A JP 35378096A JP H09224665 A JPH09224665 A JP H09224665A
- Authority
- JP
- Japan
- Prior art keywords
- sugar
- fructofuranosidase
- fructosyl
- weight
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010051210 beta-Fructofuranosidase Proteins 0.000 title claims abstract description 68
- 235000011073 invertase Nutrition 0.000 title claims abstract description 68
- CHUGKEQJSLOLHL-UHFFFAOYSA-N 2,2-Bis(bromomethyl)propane-1,3-diol Chemical compound OCC(CO)(CBr)CBr CHUGKEQJSLOLHL-UHFFFAOYSA-N 0.000 title claims abstract description 59
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 53
- 229930006000 Sucrose Natural products 0.000 claims abstract description 53
- 239000005720 sucrose Substances 0.000 claims abstract description 52
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 23
- 238000012546 transfer Methods 0.000 claims abstract description 21
- 244000005700 microbiome Species 0.000 claims abstract description 20
- -1 β-fructofuranosyl group Chemical group 0.000 claims abstract description 16
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 10
- 229930091371 Fructose Natural products 0.000 claims abstract description 9
- 239000005715 Fructose Substances 0.000 claims abstract description 9
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 9
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims abstract description 7
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims abstract description 7
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims abstract description 7
- 238000012258 culturing Methods 0.000 claims abstract description 4
- 235000000346 sugar Nutrition 0.000 claims description 100
- 238000000034 method Methods 0.000 claims description 69
- 239000000203 mixture Substances 0.000 claims description 35
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 25
- FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 claims description 24
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 23
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 23
- 235000013305 food Nutrition 0.000 claims description 22
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 17
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 16
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 16
- 239000008101 lactose Substances 0.000 claims description 16
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 15
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 15
- 150000008163 sugars Chemical class 0.000 claims description 14
- 238000004440 column chromatography Methods 0.000 claims description 13
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 12
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 10
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 8
- UWESPNLLJKPBBH-JJNZJHQXSA-N (2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-6-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)[C@@]1(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 UWESPNLLJKPBBH-JJNZJHQXSA-N 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 5
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 150000005846 sugar alcohols Chemical class 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- 238000001962 electrophoresis Methods 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 229930182479 fructoside Natural products 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 238000001502 gel electrophoresis Methods 0.000 claims description 3
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 claims description 2
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 claims description 2
- 238000001155 isoelectric focusing Methods 0.000 claims description 2
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 53
- 108090000790 Enzymes Proteins 0.000 abstract description 53
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract description 3
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 63
- 239000000047 product Substances 0.000 description 56
- 229940088598 enzyme Drugs 0.000 description 51
- 230000000694 effects Effects 0.000 description 35
- 239000007787 solid Substances 0.000 description 34
- 235000019640 taste Nutrition 0.000 description 27
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 26
- 239000000843 powder Substances 0.000 description 25
- 239000003814 drug Substances 0.000 description 21
- 235000020357 syrup Nutrition 0.000 description 21
- 239000006188 syrup Substances 0.000 description 21
- 241000186000 Bifidobacterium Species 0.000 description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 description 18
- 235000010755 mineral Nutrition 0.000 description 18
- 239000011707 mineral Substances 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 17
- 230000001603 reducing effect Effects 0.000 description 17
- 238000007796 conventional method Methods 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 230000002265 prevention Effects 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 230000003020 moisturizing effect Effects 0.000 description 14
- 238000000746 purification Methods 0.000 description 14
- 235000003599 food sweetener Nutrition 0.000 description 13
- 239000003765 sweetening agent Substances 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 12
- 239000011347 resin Substances 0.000 description 12
- 229920005989 resin Polymers 0.000 description 12
- 239000003381 stabilizer Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- 239000003456 ion exchange resin Substances 0.000 description 11
- 229920003303 ion-exchange polymer Polymers 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 239000000370 acceptor Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 238000006911 enzymatic reaction Methods 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 229940124532 absorption promoter Drugs 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- 239000007952 growth promoter Substances 0.000 description 9
- 239000001573 invertase Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 8
- 208000002925 dental caries Diseases 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 235000013372 meat Nutrition 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
- 230000003796 beauty Effects 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 238000012423 maintenance Methods 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 102000006992 Interferon-alpha Human genes 0.000 description 6
- 108010047761 Interferon-alpha Proteins 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000006072 paste Substances 0.000 description 6
- 235000014347 soups Nutrition 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 102100026189 Beta-galactosidase Human genes 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 239000008351 acetate buffer Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 108010005774 beta-Galactosidase Proteins 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000003729 cation exchange resin Substances 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 239000012228 culture supernatant Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 229960002920 sorbitol Drugs 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 241000194107 Bacillus megaterium Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000012970 cakes Nutrition 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- 238000011033 desalting Methods 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 235000021110 pickles Nutrition 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 230000003405 preventing effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 240000007154 Coffea arabica Species 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- YBHQCJILTOVLHD-YVMONPNESA-N Mirin Chemical compound S1C(N)=NC(=O)\C1=C\C1=CC=C(O)C=C1 YBHQCJILTOVLHD-YVMONPNESA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical group NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 235000011950 custard Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000004042 decolorization Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 238000005918 transglycosylation reaction Methods 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- PUTTXFZTELBTST-UHFFFAOYSA-N 6-methoxyhexane-1,2,3,4,5-pentol Chemical compound COCC(O)C(O)C(O)C(O)CO PUTTXFZTELBTST-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- 108010042889 Inulosucrase Proteins 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000013095 identification testing Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- PUTTXFZTELBTST-XZBKPIIZSA-N (2r,3r,4r,5s)-6-methoxyhexane-1,2,3,4,5-pentol Chemical compound COC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO PUTTXFZTELBTST-XZBKPIIZSA-N 0.000 description 1
- OVCJDQPBVXUBBF-UHFFFAOYSA-N 1,5-di-O-acetyl 2,3,4,6-tetra-O-methyl glucitol Natural products COCC(OC(C)=O)C(OC)C(OC)C(OC)COC(C)=O OVCJDQPBVXUBBF-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- HKKHTABTHSUDBP-WMIWJMKMSA-N 3'-ketolactose Chemical compound O[C@@H]1C(=O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O HKKHTABTHSUDBP-WMIWJMKMSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- SJVGFKBLUYAEOK-SFHVURJKSA-N 6-[4-[(3S)-3-(3,5-difluorophenyl)-3,4-dihydropyrazole-2-carbonyl]piperidin-1-yl]pyrimidine-4-carbonitrile Chemical compound FC=1C=C(C=C(C=1)F)[C@@H]1CC=NN1C(=O)C1CCN(CC1)C1=CC(=NC=N1)C#N SJVGFKBLUYAEOK-SFHVURJKSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- 229940124726 Japanese encephalitis vaccine Drugs 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
- 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 description 1
- 102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 1
- 241000270711 Malaclemys terrapin Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102100024819 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241001441723 Takifugu Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108010074506 Transfer Factor Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- OVCJDQPBVXUBBF-REWJHTLYSA-N [(2s,3r,4r,5r)-5-acetyloxy-2,3,4,6-tetramethoxyhexyl] acetate Chemical compound COC[C@@H](OC(C)=O)[C@@H](OC)[C@H](OC)[C@@H](OC)COC(C)=O OVCJDQPBVXUBBF-REWJHTLYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000008373 coffee flavor Substances 0.000 description 1
- 235000020152 coffee milk drink Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000021549 curry roux Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000022912 endospore formation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000004463 hay Substances 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 235000014109 instant soup Nutrition 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229960001388 interferon-beta Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229940041323 measles vaccine Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- WCYAALZQFZMMOM-UHFFFAOYSA-N methanol;sulfuric acid Chemical compound OC.OS(O)(=O)=O WCYAALZQFZMMOM-UHFFFAOYSA-N 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002751 molybdenum Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 150000002840 non-reducing disaccharides Chemical class 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021574 pickled cabbage Nutrition 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000002281 placental hormone Substances 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 235000012029 potato salad Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229930188195 rebaudioside Natural products 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- VBJGJHBYWREJQD-UHFFFAOYSA-M sodium;dihydrogen phosphate;dihydrate Chemical compound O.O.[Na+].OP(O)([O-])=O VBJGJHBYWREJQD-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007239 soil extract medium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000009633 stab culture Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 229940098466 sublingual tablet Drugs 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000006098 transglycosylation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000012773 waffles Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Confectionery (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Seasonings (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術的分野】本発明は、フラクトシル転
移能の高い新規なβ−フラクトフラノシダーゼと、その
製造方法及び用途に関する。TECHNICAL FIELD The present invention relates to a novel β-fructofuranosidase having a high fructosyl transfer ability, a method for producing the same and use thereof.
【0002】[0002]
【従来の技術】蔗糖と他の糖質とを原料として、β−フ
ラクトフラノシダーゼ(別名フルクトシルトランスフェ
ラーゼ)の糖転移作用により生成されるフラクトシル転
移糖、例えば、キシロシルフラクトシド、ラクトスクロ
ースなどは、抗う蝕性、あるいはビフィズス菌増殖促進
性などの性質を有することから、食品、医薬品分野にお
いて注目されているオリゴ糖である。2. Description of the Related Art A fructosyl-transferring sugar, such as xylosylfructoside and lactosucrose, which is produced by the transglycosylation activity of β-fructofuranosidase (also known as fructosyltransferase) from sucrose and other sugars It is an oligosaccharide that has attracted attention in the fields of foods and pharmaceuticals because it has properties such as caries resistance and bifidobacteria growth promoting property.
【0003】これらのフラクトシル転移糖を生成するβ
−フラクトフラノシダーゼとして、微生物起源のアルス
ロバクター・スピーシーズ K−1(Arthroba
cter sp. K−1)、及びバチルス・メガテリ
ウム(Bacillus megaterium) I
FO 13498の産生する酵素が知られている。Β that produces these fructosyl transfer sugars
-As a fructofuranosidase, Arthrobacter species K-1 (Arthroba spp.
cter sp. K-1), and Bacillus megaterium I
The enzyme produced by FO 13498 is known.
【0004】アルスロバクター・スピーシーズ K−1
のβ−フラクトフラノシダーゼは、『アグリカルチュラ
ル・アンド・バイオロジカル・ケミストリー(Agri
cultural and Biological C
hemistry)』、第54巻、第4号、913乃至
919頁、(1990年)によれば、その反応至適pH
が6.5乃至6.8とされている。このpH領域では、
工業的な酵素反応の温度条件において、糖質の褐変が起
こりやすく、とくにフラクトースが生成する反応におい
てその傾向が顕著であり、反応糖液の精製過程における
脱色操作に多大の負荷をかけることが懸念される。ま
た、バチルス・メガテリウム IFO 13498のβ
−フラクトフラノシダーゼは、特開平4−200386
号公報に示されているように、その反応至適pHは6.
0であり、その条件下での酵素反応液の褐変の程度は低
いものと思われる。しかしながら、この酵素の至適温度
が40乃至45℃と低く、この付近の温度での酵素反応
においては、微生物汚染の心配がある。Arthrobacter Species K-1
Β-fructofuranosidase is a product of “Agricultural and Biological Chemistry (Agri
cultural and Biological C
the optimum pH of the reaction according to "History", Vol. 54, No. 4, 913 to 919, (1990).
Is set to 6.5 to 6.8. In this pH range,
Under industrial temperature conditions of enzymatic reaction, sugar browning is likely to occur, and this tendency is particularly noticeable in the reaction that produces fructose, which may impose a great load on the decolorization operation in the purification process of the reaction sugar solution. To be done. In addition, β of Bacillus megaterium IFO 13498
-Fructofuranosidase is described in JP-A-4-200386.
As shown in the publication, the optimum pH of the reaction is 6.
It is 0, and the degree of browning of the enzyme reaction solution under that condition is considered to be low. However, the optimum temperature of this enzyme is as low as 40 to 45 ° C., and there is concern about microbial contamination in the enzyme reaction at temperatures around this temperature.
【0005】[0005]
【発明が解決しようとする課題】本発明は、フラクトシ
ル転移能が高く、工業的実施に有利なβ−フラクトフラ
ノシダーゼと、該酵素を利用したフラクトシル転移糖の
製造方法,並びにその用途を提供するものである。DISCLOSURE OF THE INVENTION The present invention provides β-fructofuranosidase, which has a high fructosyl transfer ability and is advantageous in industrial practice, a method for producing a fructosyl transfer sugar using the enzyme, and its use. It is a thing.
【0006】[0006]
【課題を解決するための手段】本発明者らは、上記課題
を解決するために、反応の至適温度が高く、至適pHが
糖質の安定な弱酸性域にあり、しかも糖転移能の高い新
規なβ−フラクトフラノシダーゼを求めて、その酵素を
産生する微生物を広く検索した。その結果、岡山市の土
壌から分離したバチルス(Bacillus)属に属す
る新規な微生物V230が、目的とするβ−フラクトフ
ラノシダーゼを産生することを見いだし、更に、本酵素
を、蔗糖とそれ以外の糖質とを含有する溶液に作用させ
ることにより、フラクトシル転移糖含有糖質の製造方法
を確立し、併せてこの糖質を含有せしめた組成物を確立
して本発明を完成した。In order to solve the above-mentioned problems, the present inventors have found that the optimum temperature of the reaction is high, the optimum pH is in the stable weak acidic region of sugar, and the sugar transfer ability is high. In search of a novel β-fructofuranosidase with high activity, microorganisms producing the enzyme were extensively searched. As a result, it was found that a novel microorganism V230 belonging to the genus Bacillus isolated from the soil of Okayama city produces the desired β-fructofuranosidase, and further, this enzyme was added to sucrose and other sugars. The present invention was completed by establishing a method for producing a saccharide containing a fructosyl-transferred saccharide by allowing it to act on a solution containing a saccharide, and also establishing a composition containing this saccharide.
【0007】以下、本発明における新規微生物バチルス
属に属する微生物V230の同定試験結果を示す。な
お、同定試験は、『微生物の分類と同定』(長谷川武治
編、学会出版センター、1985年)に準拠して行っ
た。The identification test results of the microorganism V230 belonging to the genus Bacillus of the novel microorganism of the present invention are shown below. The identification test was performed according to "Classification and Identification of Microorganisms" (Takeshi Hasegawa, Academic Society Publishing Center, 1985).
【0008】〈A 細胞形態〉 (1)肉汁寒天培養、27℃、培養1日:1.0乃至
1.5×3.0乃至7.5μmの桿菌。単独、希に対を
なし、連鎖した細胞も観察される。周鞭毛による運動性
あり。非抗酸性。グラム染色不定。ポリ−β−ヒドロキ
シブチレートを蓄積しない。培養4日で内生胞子を極希
に認める。 (2)ポテトエキス・ペプトン・グルコース寒天培地、
27℃、培養1日:0.9乃至1.5×2.7乃至6.0
μmの桿菌。単独、希に対をなし、連鎖した細胞も観察
される。運動性あり。グラム染色不定。内生胞子形成。
胞子着生位置は細胞の末端で、胞子のうの膨らみ無し。
胞子は0.8乃至1.0×1.0乃至1.6μmの楕
円。土壌エキス培地を用いた培養でも胞子形成を認め
る。<A Cell Morphology> (1) Meat broth agar culture, 27 ° C., 1 day of culture: 1.0 to 1.5 × 3.0 to 7.5 μm bacilli. Single, rarely paired and linked cells are also observed. There is motility due to periflagellates. Non-acidic. Gram stain variable. Does not accumulate poly-β-hydroxybutyrate. Extremely rare endospores are observed after 4 days of culture. (2) potato extract / peptone / glucose agar medium,
27 ° C., 1 day of culture: 0.9 to 1.5 × 2.7 to 6.0
μm bacilli. Single, rarely paired and linked cells are also observed. There is mobility. Gram stain variable. Endospore formation.
The spore settlement position is at the end of the cell, with no swelling of the sporangium.
The spores are ellipses of 0.8 to 1.0 × 1.0 to 1.6 μm. Spore formation is also observed in culture using a soil extract medium.
【0009】 〈B 培養的性質〉 (1)肉汁寒天平板培養、27℃ 形状 :円形、大きさは1日で1.0乃至1. 5mm。3日で1.5乃至3mm。 周縁 :全縁 隆起 :台状 光沢 :鈍光 表面 :平滑〜疣状 透明度 :半透明〜不透明 色調 :クリーム色 (2)肉汁寒天斜面培養、27℃ 生育度 :良好 形状 :糸状。隆起は薄く、表面は平滑で湿光 〜鈍光、半透明、クリーム色 (3)肉汁ゼラチン穿刺培養、27℃ :液化<B Culture Properties> (1) Meat broth agar plate culture, 27 ° C. Shape: circular, size 1.0 to 1. 5 mm. 1.5 to 3 mm in 3 days. Edge: All edges Raised: Trapezoidal Luster: Dull light Surface: Smooth to verrucous Transparency: Semi-transparent to opaque Color tone: Cream (2) Meat agar slope culture, 27 ° C Growth: Good shape: Filiform. Protuberance is thin, surface is smooth, wet light to dull light, translucent, cream color (3) Meat juice gelatin stab culture, 27 ° C: liquefaction
【0010】 〈C 生理学的性質〉 (1)硝酸塩の還元性 :陽性 (2)脱窒反応 :陰性 (3)メチルレッド試験 :陰性 (4)VP試験 :陰性 (5)インドールの生成 :陰性 (6)硫化水素の生成 :陰性 (7)澱粉の分解 :陽性 (8)カゼインの分解 :陰性 (9)ポリ−β−ヒドロキシブチレートの蓄積 :陰性 (10)プロトカテク酸の分解 :陰性 (11)クエン酸の利用 :陰性 (12)無機窒素源の利用 :アンモニウム塩および硝酸塩ともに利 用できる。 (13)色素の生成 :陰性 (14)蛍光色素の生成 :陰性 (15)ウレアーゼ :陽性 (16)オキシダーゼ :陽性 (17)カタラーゼ :陽性 (18)生育の範囲 :pH5乃至8、温度15乃至45℃。 (19)酸素に対する態度 :好気性 (20)炭素源の利用と酸生成の有無 利用性 酸生成能 D−グルコース 利用する 陽性 D−ガラクトース 利用する 陽性 D−マンノース 利用する 陽性 D−フラクトース 利用する 陽性 L−アラビノース 利用する 陽性 D−キシロース 利用する 陽性 L−ラムノース 利用する 陽性 マルトース 利用する 陽性 蔗糖 利用する 陽性 乳糖 利用する 陰性 トレハロース 利用する 陽性 ラフィノース 利用する 陽性 ソルビトール 利用する 陽性 マンニトール 利用する 陽性 ズルチトール 利用しない 陰性 グリセロール 利用しない 陰性 デキストリン 利用する 陽性 (21)アミノ酸の脱炭酸試験 :L−リジン、L−アルギニン、オルニ チンのいずれに対しても陰性。 (22)アミノ酸の利用 :L−グルタミン酸ナトリウム、L−ア スパラギン酸ナトリウム、L−アルギ ニン、L−トリプトファン、L−ヒス チジン、L−バリン、D−アラニンの いずれも利用する。 (23)DNase :陰性 (24)3−ケト乳糖の生成 :陰性 (25)DNAのG−C含量 :41% (26)細胞壁ジアミノ酸 :meso−ジアミノピメリン酸<C Physiological Properties> (1) Reducibility of nitrate: Positive (2) Denitrification reaction: Negative (3) Methyl red test: Negative (4) VP test: Negative (5) Indole formation: Negative ( 6) Production of hydrogen sulfide: Negative (7) Decomposition of starch: Positive (8) Decomposition of casein: Negative (9) Accumulation of poly-β-hydroxybutyrate: Negative (10) Degradation of protocatechuic acid: Negative (11) Use of citric acid: Negative (12) Use of inorganic nitrogen source: Both ammonium salt and nitrate can be used. (13) Dye formation: Negative (14) Fluorescence dye formation: Negative (15) Urease: Positive (16) Oxidase: Positive (17) Catalase: Positive (18) Growth range: pH 5 to 8, temperature 15 to 45 ° C. (19) Attitude toward oxygen: Aerobic (20) Utilization of carbon source and presence / absence of acid production Availability Acid production ability D-glucose utilization positive D-galactose utilization positive D-mannose utilization positive D-fructose utilization positive L-arabinose used Positive D-xylose used positive L-rhamnose used positive Maltose used positive Sucrose used positive Lactose used negative Trehalose used positive Raffinose used positive Sorbitol used positive Mannitol used positive Zlutitol not used negative Glycerol not used Negative dextrin used Positive (21) Amino acid decarboxylation test: Negative to any of L-lysine, L-arginine and ornithine. (22) Use of amino acid: L-glutamate sodium, L-aspartate sodium, L-arginine, L-tryptophan, L-histidine, L-valine, and D-alanine are all used. (23) DNase: Negative (24) 3-Keto-lactose production: Negative (25) G-C content of DNA: 41% (26) Cell wall diamino acid: meso-diaminopimelic acid
【0011】以上の菌学的性質に基づいて、『バージー
ズ・マニュアル・オブ・システマティック・バクテリオ
ロジー(Bergey’s Manual of Sy
stematic Bacteriology Vol
ume 2)』、第2巻、(1986年)を参考にして
公知菌との異同を検討した。その結果、本菌は、グラム
染色は不定であったが、好気性で、内生胞子を形成した
ことから、バチルス属に属する微生物であることが判明
した。さらに、本菌は、上記の菌学的諸性質からバチル
ス・メガテリウム(Bacillus megater
ium)に近いことがわかるが、内生胞子は細胞の末端
に形成されること、カゼインの分解性陰性、クエン酸の
利用性陰性、10℃での生育陰性などの点でバチルス・
メガテリウムとは明らかに異なることが判明した。Based on the above-mentioned mycological properties, "Bergey's Manual of Systematic Bacteriology (Bergey's Manual of Sy
structural Bacteriology Vol
ume 2) ”, Vol. 2, (1986), and examined the difference between the known bacteria. As a result, this bacterium was aerobic and formed endospores, although Gram's staining was indeterminate, and thus it was found to be a microorganism belonging to the genus Bacillus. Furthermore, this bacterium is a Bacillus megaterium (Bacillus megaterium) from the above-mentioned mycological properties.
However, the endospores are formed at the end of the cell, casein degradability is negative, citric acid availability is negative, and growth at 10 ° C is negative.
It turned out to be distinctly different from megaterium.
【0012】これらの結果から、本発明者等は、本微生
物をバチルス・スピーシーズ(Bacillus s
p.)V230と命名し、平成7年3月24日付で、茨
城県つくば市にある通商産業省工業技術院生命工学工業
技術研究所に寄託し、受託番号FERM BP−505
4として受託された。[0012] From these results, the present inventors have confirmed that the microorganism of the present invention is Bacillus species.
p. ) Named V230, deposited on March 24, 1995 at the Institute of Biotechnology, Institute of Biotechnology, Ministry of International Trade and Industry, Tsukuba City, Ibaraki Prefecture, with deposit number FERM BP-505.
Commissioned as 4.
【0013】本発明では、本菌株のみならず、その変異
株なども使用することができる。In the present invention, not only the strain of the present invention but also mutants thereof can be used.
【0014】本発明の微生物の培養に用いる培地は、本
微生物が生育でき、本発明の酵素を産生するものであれ
ばよく、合成培地および天然培地のいずれでもよい。炭
素源としては、本微生物が資化できる物であればよく、
例えば、蔗糖、乳糖、マルトース、デキストリン、澱粉
などの糖質、糖蜜および酵母エキスなどの糖含有物など
を使用することができる。培地におけるこれらの炭素源
の濃度は炭素源の種類により適宜選択される。例えば、
培養液の蔗糖の濃度は、20w/v%以下が望ましく、
菌の生育および増殖からは、通常、5w/v%以下が好
ましい。窒素源としては、例えば、アンモニウム塩、硝
酸塩などの無機窒素化合物、及び、例えば、尿素、コー
ン・スティープ・リカー、カゼイン、ペプトン、酵母エ
キス、肉エキスなどの有機窒素含有物が用いられる。ま
た、無機成分としては、例えば、カルシウム塩、マグネ
シウム塩、カリウム塩、ナトリウム塩、リン酸塩、マン
ガン塩、亜鉛塩、鉄塩、銅塩、モリブデン塩、コバルト
塩などが、必要に応じて適宜用いられる。The medium used for culturing the microorganism of the present invention may be any one that can grow the microorganism and produce the enzyme of the present invention, and may be either a synthetic medium or a natural medium. Any carbon source may be used as long as it can be assimilated by the microorganism.
For example, sugars such as sucrose, lactose, maltose, dextrin and starch, sugar-containing substances such as molasses and yeast extract and the like can be used. The concentration of these carbon sources in the medium is appropriately selected depending on the type of the carbon source. For example,
The concentration of sucrose in the culture solution is preferably 20 w / v% or less,
From the viewpoint of growth and proliferation of bacteria, usually 5 w / v% or less is preferable. Examples of the nitrogen source include inorganic nitrogen compounds such as ammonium salts and nitrates, and organic nitrogen-containing substances such as urea, corn steep liquor, casein, peptone, yeast extract and meat extract. Further, as the inorganic component, for example, calcium salt, magnesium salt, potassium salt, sodium salt, phosphate salt, manganese salt, zinc salt, iron salt, copper salt, molybdenum salt, cobalt salt, etc. are appropriately used as necessary. Used.
【0015】培養は、通常、温度15乃至45℃、好ま
しくは25乃至37℃、pH5乃至8、好ましくはpH
5.5乃至7.5から選ばれる条件で、好気的に行われ
る。培養時間は、本微生物が増殖し得る時間であればよ
く、好ましくは5乃至100時間である。また、培養液
の溶存酸素濃度には特に制限はないが、通常は、0.5
乃至20ppmが好ましい。そのために、通気量を調節
したり、攪拌したり、酸素を使用したり、また、培養槽
内の圧力を高めるなどの手段が採用される。また、培養
方式は、回分培養または連続培養のいずれでもよい。The culture is usually carried out at a temperature of 15 to 45 ° C., preferably 25 to 37 ° C., pH 5 to 8, preferably pH.
It is performed aerobically under the condition selected from 5.5 to 7.5. The culture time may be any time as long as the present microorganism can grow, and is preferably 5 to 100 hours. The dissolved oxygen concentration of the culture solution is not particularly limited, but usually 0.5
To 20 ppm is preferred. For that purpose, means such as adjusting the amount of aeration, stirring, using oxygen, and increasing the pressure in the culture tank are adopted. Further, the culture system may be either batch culture or continuous culture.
【0016】このようにして、微生物を培養した後、得
られる培養物から本発明の酵素を回収する。本酵素活性
は、培養物の菌体外培養液に認められ、菌体外培養液を
粗酵素として回収すればよく、また、培養物全体を粗酵
素として用いることもできる。菌体外培養液と菌体との
分離には、通常の固液分離手段が採用される。例えば、
培養物そのものをそのまま遠心分離する手段、培養物に
濾過助剤を加えたり、あるいは、濾過助剤をプレコート
したプレコートフィルターにより濾過分離する手段、平
膜、中空糸膜などを用いる膜濾過分離する手段などが採
用される。菌体外培養液をそのまま粗酵素液として用い
ることもできるが、好ましくは濃縮して用いる。例え
ば、硫安塩析法、アセトン及びアルコール沈澱法、平
膜、中空糸膜などを用いる膜濃縮法などが採用される。After culturing the microorganism in this manner, the enzyme of the present invention is recovered from the resulting culture. This enzyme activity is found in the extracellular culture solution of the culture, and the extracellular culture solution may be recovered as a crude enzyme, or the entire culture can be used as a crude enzyme. An ordinary solid-liquid separation means is adopted for separating the extracellular culture liquid from the bacterial cells. For example,
A means for centrifuging the culture itself as it is, a means for adding a filter aid to the culture, or a means for filtering and separating with a precoat filter precoated with a filter aid, a means for membrane filtration using a flat membrane, a hollow fiber membrane, etc. Are adopted. Although the extracellular culture solution can be used as a crude enzyme solution as it is, it is preferably concentrated before use. For example, an ammonium sulfate salting-out method, an acetone and alcohol precipitation method, a membrane concentration method using a flat membrane, a hollow fiber membrane and the like are adopted.
【0017】更に、菌体外培養液およびその濃縮物は、
固定化することもできる。例えば、イオン交換体への結
合法、樹脂及び膜などとの共有結合・吸着法、高分子物
質を用いた包括法などが採用される。Further, the extracellular culture solution and its concentrate are
It can also be fixed. For example, a binding method to an ion exchanger, a covalent binding / adsorption method with a resin or a membrane, an encapsulation method using a polymer substance, etc. are adopted.
【0018】粗酵素は、そのまま用いてもよいが、精製
して使用することもできる。例えば、菌体外培養液を硫
安塩析して濃縮した粗酵素標品を透析後、DEAE−ト
ヨパール樹脂を用いる陰イオン交換カラムクロマトグラ
フィー、続いて、ブチルトヨパール樹脂を用いる疎水カ
ラムクロマトグラフィー、再度DEAE−トヨパール樹
脂を用いる陰イオン交換カラムクロマトグラフィーによ
り精製することによって、電気泳動的に単一な酵素を得
ることができる。The crude enzyme may be used as it is, or may be purified before use. For example, after dialysis of a crude enzyme preparation obtained by salting out the extracellular culture solution with ammonium sulfate and concentrating it, anion exchange column chromatography using DEAE-Toyopearl resin, followed by hydrophobic column chromatography using butyl Toyopearl resin, By purifying again by anion exchange column chromatography using DEAE-Toyopearl resin, an electrophoretically single enzyme can be obtained.
【0019】このようにして得られる本発明のβ−フラ
クトフラノシダーゼは、下記の理化学的性質を有する。 (1) 作用 蔗糖、ラフィノース及びエルロースのβ−フラクトフラ
ノシド結合を加水分解して、フラクトースを遊離する。
また、これらβ−フラクトフラノシド結合を有する糖質
を糖供与体として、他の糖質、糖アルコール及びアルコ
ール類から選ばれる受容体にβ−フラクトフラノシル基
の転移を触媒する。 (2) 分子量 SDS−ゲル電気泳動法で、49,000±5,000
ダルトン (3) 等電点 アンフォライン含有電気泳動法で、4.6±0.5 (4) 至適pH 温度40℃、10分間反応で、約5.5乃至6.0 (5) 至適温度 pH6.0、10分間反応で、カルシウムイオン非存在
下で45℃付近,カルシウムイオン存在下で50℃付近 (6) pH安定性 温度4℃、24時間保持の条件で、pH約5.0乃至
8.0の範囲で安定 (7) 温度安定性 pH6.0、1時間保持の条件で、45℃付近まで安定 (8) 阻害 1mMのCu++、Pb++、Fe++、Fe+++ 、Hg++で
阻害を受ける。The β-fructofuranosidase of the present invention thus obtained has the following physicochemical properties. (1) Action Hydrolyzes β-fructofuranoside bonds of sucrose, raffinose and erulose to release fructose.
Further, the sugar having these β-fructofuranoside bonds is used as a sugar donor to catalyze the transfer of the β-fructofuranosyl group to an acceptor selected from other sugars, sugar alcohols and alcohols. (2) Molecular weight By SDS-gel electrophoresis, 49,000 ± 5,000.
Dalton (3) Isoelectric focusing Amphoraine-containing electrophoresis method 4.6 ± 0.5 (4) Optimum pH temperature 40 ° C, 10 minutes reaction, about 5.5 to 6.0 (5) Optimum Temperature pH 6.0 for 10 minutes, around 45 ° C in the absence of calcium ions, around 50 ° C in the presence of calcium ions (6) pH stability pH of about 5.0 at 24 ° C for 24 hours. Stable in the range of to 8.0 (7) Temperature stability pH 6.0, stable up to about 45 ° C under the condition of 1 hour holding (8) Inhibition 1 mM Cu ++ , Pb ++ , Fe ++ , Fe + Inhibited by ++ and Hg ++ .
【0020】本発明のβ−フラクトフラノシダーゼの活
性は、次のようにして測定する。基質として蔗糖1.0
w/v%を含む水溶液(20mM酢酸緩衝液、pH6.
0、5mM塩化カルシウムを含む)5mlに酵素液0.
2mlを加え、40℃で10分間反応させた後、ソモギ
ー銅液を加え反応を停止させ、還元力をソモギー・ネル
ソン法により測定する。対照として、あらかじめ100
℃で10分間加熱することにより失活させた酵素液を用
いて、同様に測定する。酵素活性1単位は、上記の測定
方法で、1分間に2マイクロモルのグルコースに相当す
る還元力を増加させる酵素量、と定義する。The activity of β-fructofuranosidase of the present invention is measured as follows. Sucrose 1.0 as a substrate
Aqueous solution containing w / v% (20 mM acetate buffer, pH 6.
(Containing 0.5 mM calcium chloride) to 0.5 ml of the enzyme solution.
After adding 2 ml and reacting at 40 ° C. for 10 minutes, a somoggy copper solution is added to stop the reaction, and the reducing power is measured by the Somogy Nelson method. As a control, 100
The same measurement is performed using the enzyme solution inactivated by heating at 0 ° C for 10 minutes. One unit of enzyme activity is defined as the amount of enzyme that increases the reducing power corresponding to 2 μmol glucose per minute by the above measurement method.
【0021】本発明のβ−フラクトフラノシダーゼは、
蔗糖に作用して、グルコースとフラクトースを生成する
が、蔗糖濃度を高めても、蔗糖分子間の転移反応は起こ
りにくく、蔗糖よりも分子量の大きいオリゴ糖の生成は
極めて少ない。しかし、蔗糖を糖供与体とし、他の適切
な糖質、例えば、キシロース、ガラクトース、乳糖、マ
ルトース、イソマルトースなどの還元性糖質を受容体と
して本酵素を作用させた場合、それぞれの還元性糖質に
フラクトシル基を転移して、キシロシルフラクトシド、
ガラクトシルフラクトシド、ラクトスクロース(別名、
ラクトシルフラクトシド)、エルロース(別名、マルト
シルフラクトシド)、イソマルトシルフラクトシドを生
成する。また、他の糖質として、トレハロース、ネオト
レハロースなどのグルコースからなる非還元性二糖類を
受容体として、同様に本酵素を作用させた場合、フラク
トシルトレハロース、フラクトシルネオトレハロースを
生成する。単糖類、二糖類のみならず、それ以上の重合
度のキシロオリゴ糖、ガラクトオリゴ糖、マルトオリゴ
糖、イソマルトオリゴ糖などのオリゴ糖類、また、ソル
ビトール、マルチトールなどの糖アルコール類も受容体
となりうる。受容体としては2種以上を同時に用いるこ
とも有利に実施できる。また、供与体としては、蔗糖以
外に、例えば、ラフィノース、エルロースなどβ−フラ
クトフラノシド結合を有するオリゴ糖を用いることもで
きる。The β-fructofuranosidase of the present invention is
It acts on sucrose to produce glucose and fructose, but even if the sucrose concentration is increased, the transfer reaction between sucrose molecules is unlikely to occur, and the production of oligosaccharides having a larger molecular weight than sucrose is extremely small. However, when sucrose is used as a sugar donor and another suitable sugar, for example, a reducing sugar such as xylose, galactose, lactose, maltose, or isomaltose is used as an acceptor to act the enzyme, each reducing property is reduced. Transferring the fructosyl group to sugar, xylosylfructoside,
Galactosyl fructoside, lactosucrose (aka,
It produces lactosylfructoside), erulose (also known as maltosylfructoside), and isomaltosylfructoside. In addition, when the present enzyme is similarly acted by using a non-reducing disaccharide composed of glucose such as trehalose or neotrehalose as another sugar as an acceptor, fructosyl trehalose and fructosyl neotrehalose are produced. Not only monosaccharides and disaccharides, but also oligosaccharides having a higher degree of polymerization such as xylooligosaccharides, galactooligosaccharides, maltooligosaccharides and isomaltooligosaccharides, and sugar alcohols such as sorbitol and maltitol can be acceptors. It is also advantageous to use two or more types of receptors simultaneously. In addition to sucrose, oligosaccharides having a β-fructofuranoside bond such as raffinose and erulose can also be used as the donor.
【0022】本発明のβ−フラクトフラノシダーゼを用
いたフラクトシル転移糖生成反応における基質濃度は、
特に限定されないが、工業的には10w/w%(以下、
本明細書では、特にことわらない限り、w/w%を%と
略称する。)以上、望ましくは20乃至60%が好適で
ある。反応温度は、基質存在下で酵素が失活しない温
度、すなわち60℃付近までで行えばよいが、好ましく
は約50乃至55℃の範囲を用いる。反応pHは、通
常、約3.5乃至8.0の範囲に調整すればよいが、好
ましくはpH約4.5乃至6.5の範囲に調整すればよ
い。反応時間は、酵素反応の進行具合により適宜選択す
ればよく、通常、基質固形物1グラム当たり約0.1乃
至50単位の使用量で、0.1乃至100時間程度であ
る。The substrate concentration in the fructosyl-transferring sugar production reaction using the β-fructofuranosidase of the present invention is
Although not particularly limited, industrially 10 w / w% (hereinafter,
In the present specification, w / w% is abbreviated as% unless otherwise specified. ) Or more, and preferably 20 to 60%. The reaction temperature may be a temperature at which the enzyme is not inactivated in the presence of the substrate, that is, up to about 60 ° C., preferably about 50 to 55 ° C. The reaction pH may be usually adjusted to a range of about 3.5 to 8.0, preferably pH of about 4.5 to 6.5. The reaction time may be appropriately selected depending on the progress of the enzymatic reaction, and is usually about 0.1 to 100 hours at a usage amount of about 0.1 to 50 units per gram of the solid substrate.
【0023】フラクトシル転移糖の生成率は、酵素反応
液の基質濃度、用いる受容体の種類、反応条件などによ
って異なる。例えば、20%蔗糖と20%乳糖を基質と
して用いた場合、ラクトスクロースの生成率は、最大約
40%である。The production rate of fructosyl-transferred sugar varies depending on the substrate concentration of the enzyme reaction solution, the type of acceptor used, the reaction conditions and the like. For example, when 20% sucrose and 20% lactose are used as substrates, the production rate of lactosucrose is about 40% at maximum.
【0024】反応液は、常法により、濾過、遠心分離な
どして不溶物を除去した後、活性炭による脱色、H型、
OH型イオン交換樹脂による脱塩などの精製工程を経た
後、濃縮し、シラップ状製品にする。必要ならば、更に
乾燥して粉末状製品にすることも随意である。The reaction solution is filtered, centrifuged, etc. to remove insoluble materials by a conventional method, and then decolorized with activated carbon, H type,
After a purification process such as desalting with an OH type ion exchange resin, the product is concentrated to give a syrup-like product. If desired, further drying into a powdered product is optional.
【0025】また、転移糖含量を高めるために、酵素反
応液から目的とする転移糖を分離、精製して、フラクト
シル転移糖高含有物にすることもできる。その方法とし
ては、例えば、インベルターゼ欠損酵母を用いた発酵法
により単糖類を除去する方法(酵母発酵法)、アルカリ
性溶液にして加熱処理することにより還元性糖質を分解
する方法(アルカリ処理法)、膜濾過法、カラムクロマ
トグラフィーなどにより、夾雑糖類を分離除去する方法
が、適宜採用できる。とりわけ、特開昭58−2379
9号公報、特開昭58−72598号公報などに開示さ
れている塩型強酸性カチオン交換樹脂を用いるカラムク
ロマトグラフィーにより、夾雑糖類を除去して目的とす
るフラクトシル転移糖高含有画分を採取する方法は、工
業的規模で有利に実施できる。この際、公知の固定床方
式、移動床方式、疑似移動床方式のいずれの方法を採用
することも随意である。Further, in order to increase the content of transferase, it is also possible to separate and purify the target saccharide from the enzyme reaction solution to obtain a high fructosyl transferase content. Examples of the method include a method of removing monosaccharides by a fermentation method using an invertase-deficient yeast (yeast fermentation method), and a method of decomposing reducing sugars by heat treatment with an alkaline solution (alkaline treatment method). A method for separating and removing contaminant saccharides by a membrane filtration method, column chromatography, etc. can be appropriately adopted. Above all, JP-A-58-2379
No. 9 and JP-A No. 58-72598 disclose column chromatography using a salt-type strongly acidic cation exchange resin to remove contaminating saccharides and collect a desired fraction containing a high fructosyl transfer sugar. The method can be advantageously carried out on an industrial scale. At this time, any of the known fixed bed method, moving bed method, and pseudo moving bed method may be adopted.
【0026】夾雑糖質を分離した液は、常法により、瀘
過、遠心分離などして不溶物を除去した後、活性炭によ
る脱色、H型、OH型イオン交換樹脂による脱塩などの
精製工程を経て、濃縮し、シラップ状製品にする。必要
ならば、更に、噴霧乾燥などの方法で乾燥して、粉末状
製品にすることも随意である。The liquid from which the contaminant sugars have been separated is subjected to a purification process such as decolorization with activated carbon and desalting with an H-type or OH-type ion exchange resin after removing insolubles by a conventional method such as filtration and centrifugation. And concentrate to give a syrup-like product. If necessary, it is optionally further dried by a method such as spray drying to give a powdered product.
【0027】このようにして得られる本発明のβ−フラ
クトフラノシダーゼにより生成されるフラクトシル転移
糖含有糖質は、通常フラクトシル転移糖を固形物当たり
5%以上、望ましくは10%以上含有している。The thus-obtained β-fructofuranosidase-containing sugar of the present invention containing fructosyl-transferring sugars usually contains 5% or more, preferably 10% or more, of fructosyl-transferring sugar per solid matter. .
【0028】以上述べた方法で製造されるフラクトシル
転移糖含有糖質は、味質良好な甘味を有し、また、浸透
圧調節性、保湿性、照付与性、結晶防止性、澱粉老化防
止性などの性質を有し、また、抗う蝕性、ビフィズス菌
増殖促進性、ミネラル吸収促進性などの機能をも有し、
広く飲食物、嗜好物、飼料、餌料、化粧品、医薬品、成
形物など、更には、生活用品、農林水産用品、試薬、化
学工業用品などの各種組成物に有利に利用される。The fructosyl-transferred sugar-containing sugar produced by the above-mentioned method has a good taste and sweetness, and also has an osmotic pressure adjusting property, a moisturizing property, a light-imparting property, a crystallization preventing property and a starch aging preventing property. In addition, it also has functions such as caries resistance, bifidobacteria growth promotion, mineral absorption promotion, etc.,
Widely used in various compositions such as food and drink, favorite foods, feeds, feeds, cosmetics, pharmaceuticals, molded products, and also household products, agricultural, forestry and fishery products, reagents, chemical industrial products and the like.
【0029】フラクトシル転移糖含有糖質は、甘味付け
のための調味料としてそのまま使用することができる
が、必要ならば、例えば、粉飴、ブドウ糖、マルトー
ス、トレハロース、蔗糖、異性化糖、蜂蜜、メイプルシ
ュガー、ソルビトール、マルチトール、ラクチトール、
ジヒドロカルコン、ステビオシド、α−グリコシルステ
ビオシド、レバウディオシド、グリチルリチン、L−ア
スパルチル−L−フェニルアラニンメチルエステル、サ
ッカリン、グリシン、アラニンなどのような他の甘味料
の一種または二種以上の適量と混合して使用してもよ
く、また必要ならば、デキストリン、澱粉、乳糖などの
ような増量剤と混合して使用することもできる。The fructosyl-transferred sugar-containing sugar can be used as it is as a seasoning for sweetening, but if necessary, for example, starch syrup, glucose, maltose, trehalose, sucrose, isomerized sugar, honey, Maple sugar, sorbitol, maltitol, lactitol,
Used in admixture with one or more appropriate amounts of other sweeteners such as dihydrochalcone, stevioside, α-glycosyl stevioside, rebaudioside, glycyrrhizin, L-aspartyl-L-phenylalanine methyl ester, saccharin, glycine, alanine, etc. It may be used, and if necessary, it can be used by mixing with a bulking agent such as dextrin, starch, lactose and the like.
【0030】また、フラクトシル転移糖含有糖質の呈味
は、酸味、塩から味、渋味、旨味、苦味などの他の呈味
を有する各種物質とよく調和するので、一般の飲食物の
甘味付け、呈味改良に、また品質改良などに有利に利用
できる。The taste of the sugar containing fructosyl-transferred sugar is in good harmony with various substances having other tastes such as sourness, salt to taste, astringency, umami and bitterness, so that the sweetness of general foods and drinks It can be advantageously used for attaching, improving taste, and improving quality.
【0031】例えば、醤油、粉末醤油、味噌、粉末味
噌、もろみ、ひしお、ふりかけ、マヨネーズ、ドレッシ
ング、食酢、三杯酢、粉末すし酢、中華の素、天つゆ、
麺つゆ、ソース、ケチャップ、たくあん漬の素、白菜漬
の素、焼肉のタレ、カレールウ、シチューの素、スープ
の素、ダシの素、複合調味料、みりん、新みりん、テー
ブルシュガー、コーヒーシュガーなど、各種調味料とし
て有利に使用できる。For example, soy sauce, powdered soy sauce, miso, powdered miso, moromi, hisoio, sprinkle, mayonnaise, dressing, vinegar, three tablespoons vinegar, powdered sushi vinegar, Chinese cabbage, tempura sauce,
Noodle soup, sauce, ketchup, pickled tuna, pickled cabbage, sauce of roasted meat, curry roux, stew, soup, soup stock, dashi stock, mixed seasonings, mirin, new mirin, table sugar, coffee sugar, etc. , Can be advantageously used as various seasonings.
【0032】また、例えば、せんべい、あられ、おこ
し、餅類、まんじゅう、ういろう、あん類、羊羮、水羊
羮、錦玉、ゼリー、カステラ、飴玉などの各種和菓子、
パン、ビスケット、クラッカー、クッキー、パイ、プリ
ン、バタークリーム、カスタードクリーム、シュークリ
ーム、ワッフル、スポンジケーキ、ドーナツ、チョコレ
ート、チューインガム、キャラメル、キャンデーなどの
洋菓子、アイスクリーム、シャーベット、などの氷菓、
果実のシロップ漬、氷蜜などのシロップ類、フラワーペ
ースト、ピーナッツペースト、フルーツペースト、スプ
レッドなどのペースト類、ジャム、マーマレード、シロ
ップ漬、糖果などの果実、野菜の加工食品類、福神漬、
べったら漬、千枚漬、らっきょう漬などの漬物類、ハ
ム、ソーセージなどの畜肉製品類、魚肉ハム、魚肉ソー
セージ、かまぼこ、ちくわ、天ぷらなどの魚肉製品、ウ
ニ、イカの塩辛、酢こんぶ、さきするめ、ふぐみりん干
しなどの各種珍味類、のり、山菜、するめ、小魚、貝な
どで製造されるつくだ煮類、煮豆、ポテトサラダ、こん
ぶ巻などの惣菜食品、乳製品、魚肉、畜肉、果実、野菜
のビン詰、缶詰類、清酒、合成酒、リキュール、洋酒な
どの酒類、紅茶、コーヒー、ココア、ジュース、炭酸飲
料、乳酸飲料、乳酸菌飲料などの清涼飲料水、プリンミ
ックス、ホットケーキミックス、即席しるこ、即席スー
プなどの即席食品、更には、離乳食、治療食、ドリンク
剤などの各種飲食物への甘味付に、呈味改良に、また、
物性改良などに有利に利用できる。Further, for example, various Japanese sweets such as rice crackers, hail, rice cakes, rice cakes, steamed buns, uiro, bean paste, yokan, water yoyo, nishikidama, jelly, castella, candy, etc.,
Bread, biscuits, crackers, cookies, pies, puddings, butter cream, custard cream, cream puffs, waffles, sponge cakes, donuts, chocolate, chewing gum, caramel, candy and other Western confectionery, ice cream, sherbet, and other frozen desserts,
Fruit syrup pickles, syrups such as ice honey, flower paste, peanut paste, fruit paste, pastes such as spreads, jam, marmalade, syrup pickles, fruits such as sugar fruit, processed foods of vegetables, Fukugami pickles,
Pickles such as Beta-ra-zuke, Sen-mai-zuke, and Rakkyo-zuke, meat products such as ham and sausage, fish ham, fish-meat sausage, fish products such as kamaboko, chikuwa, and tempura, sea urchin, salted squid, vinegared kombu, sakinume, and fugu mirin. Tsutsudani cooked with various delicacies such as dried vegetables, seaweed, edible wild plants, sardines, small fish, and shellfish, boiled beans, potato salad, prepared foods such as kelp rolls, dairy products, fish meat, meat, fruits, vegetables bottled , Canned goods, sake, synthetic liquor, liqueur, liquor such as Western liquor, tea, coffee, cocoa, juice, carbonated drink, lactic acid drink, soft drink such as lactic acid bacteria drink, pudding mix, hot cake mix, instant sirko, instant soup Improving foods, such as baby foods, therapeutic foods, sweetening to various foods and drinks such as drinks, improving taste,
It can be advantageously used for improving physical properties.
【0033】また、家畜、家禽、魚などの飼育動物のた
めに、飼料、餌料などの嗜好性の向上、あるいは、肥育
向上の目的で使用することもできる。その他、タバコ、
練歯磨、口紅、リップクリーム、内服液、錠剤、トロー
チ、肝油ドロップ、口中清涼剤、口中香剤、うがい剤な
どの各種固形物にも使用できるし、ペースト状、液状な
どにして嗜好物、化粧品、医薬品など、各種組成物への
甘味剤として、または呈味改良剤、矯味剤として、更に
は、品質改良剤として有利に利用できる。Further, it can also be used for domestic animals such as livestock, poultry and fish for the purpose of improving the palatability of feed, feed and the like, or improving the fattening. Other, cigarettes,
It can be used for various solid substances such as toothpaste, lipstick, lip balm, oral solution, tablets, troches, liver oil drops, mouth refreshing agents, mouth flavoring agents, mouthwashes, etc. , It can be advantageously used as a sweetener for various compositions such as pharmaceuticals, or as a taste improver, a corrigent, and a quality improver.
【0034】品質改良剤、安定剤としては、有効成分、
活性などを失い易い各種生理活性物質、またはこれを含
む健康食品、医薬品などに有利に適応できる。例えば、
インターフェロン−α、インターフェロン−β、インタ
ーフェロン−γ、ツモア・ネクロシス・ファクター−
α、ツモア・ネクロシス・ファクター−β、マクロファ
ージ遊走阻止因子、コロニー刺激因子、トランスファー
ファクター、インターロイキン2などのリンホカイン含
有液、インシュリン、成長ホルモン、プロラクチン、エ
リトロポエチン、卵細胞刺激ホルモン、胎盤ホルモンな
どのホルモン含有液、BCGワクチン、日本脳炎ワクチ
ン、はしかワクチン、ポリオ生ワクチン、痘苗、破傷風
トキソイド、ハブ抗毒素、ヒト免疫グロブリンなどの生
物製剤含有液、ペニシリン、エリスロマイシン、クロラ
ムフェニコール、テトラサイクリン、ストレプトマイシ
ン、硫酸カナマイシンなどの抗生物質含有液、チアミ
ン、リボフラビン、L−アスコルビン酸、肝油、カロチ
ノイド、エルゴステロール、トコフェロールなどのビタ
ミン含有液、リパーゼ、エラスターゼ、ウロキナーゼ、
プロテアーゼ、β−アミラーゼ、イソアミラーゼ、グル
カナーゼ、ラクターゼなどの酵素含有液、薬用人参エキ
ス、スッポンエキス、クロレラエキス、アロエエキス、
プロポリスエキスなどのエキス類、ウイルス、乳酸菌、
酵母などの生菌、ロイヤルゼリーなどの各種生理活性物
質も、本発明のフラクトシル転移糖含有糖質を使用する
ことによって、その有効成分、活性を失うことなく、品
質改良および/または安定化でき、安定で高品質の健康
食品や医薬品などを容易に製造できる。As the quality improver and stabilizer, active ingredients,
It can be advantageously applied to various physiologically active substances that easily lose activity, or health foods, pharmaceuticals, etc. containing the same. For example,
Interferon-α, Interferon-β, Interferon-γ, Tumor necrosis factor-
α, Tumor necrosis factor-β, macrophage migration inhibitory factor, colony stimulating factor, transfer factor, lymphokine-containing solution such as interleukin-2, insulin, growth hormone, prolactin, erythropoietin, egg cell stimulating hormone, placental hormone, etc. Liquid, BCG vaccine, Japanese encephalitis vaccine, measles vaccine, live polio vaccine, smallpox seedling, tetanus toxoid, hub antitoxin, liquid containing biologics such as human immunoglobulin, penicillin, erythromycin, chloramphenicol, tetracycline, streptomycin, kanamycin sulfate. Antibiotic-containing liquid such as, thiamine, riboflavin, L-ascorbic acid, liver oil, carotenoid, ergosterol, tocopherol-containing vitamin-containing liquid, lipase , Elastase, urokinase,
Enzyme-containing liquids such as protease, β-amylase, isoamylase, glucanase and lactase, ginseng extract, terrapin extract, chlorella extract, aloe extract,
Extracts such as propolis extract, viruses, lactic acid bacteria,
Various bioactive substances such as live bacteria such as yeast and royal jelly can also be improved in quality and / or stabilized without losing their active ingredients and activities by using the fructosyl transfer sugar-containing saccharide of the present invention, Stable and high-quality health foods and pharmaceuticals can be easily manufactured.
【0035】以上述べたように、本発明でいう組成物
は、経口的または非経口的に利用する飲食物、医薬品の
みならず、それ以外にも、例えば、化粧品、生活用品、
農林水産用品、試薬、化学工業用品など広範な用途を有
する。As described above, the composition of the present invention is not limited to foods and drinks or medicines used orally or parenterally, but other than that, for example, cosmetics, daily necessities,
It has a wide range of applications such as agricultural, forestry and fishery products, reagents, and chemical industry products.
【0036】また、これら組成物に、本発明のフラクト
シル転移糖含有糖質を含有せしめる方法は、その製品が
完成するまでの工程で含有せしめればよく、例えば、混
和、溶解、浸漬、浸透、散布、塗布、噴霧、注入、固化
などの公知の方法が適宜選ばれる。その含有せしめる量
は、組成物によっても異なるが、一般的には、フラクト
シル転移糖として、0.1%以上、望ましくは0.5%
以上の量が好適である。The method of incorporating the fructosyl transfer sugar-containing saccharide of the present invention into these compositions may be such that it is contained in the steps until the product is completed. For example, mixing, dissolving, dipping, permeating, Known methods such as spraying, coating, spraying, pouring, and solidifying are appropriately selected. The amount to be contained varies depending on the composition, but it is generally 0.1% or more, preferably 0.5% as the fructosyl transfer sugar.
The above amount is suitable.
【0037】次に、実験により、本発明をさらに具体的
に説明する。Next, the present invention will be described more specifically by experiments.
【0038】〈実験1 酵素の生産〉蔗糖1.0w/v
%、ポリペプトン0.5w/v%、酵母エキス0.1w
/v%、リン酸二カリウム0.1w/v%、リン酸一ナ
トリウム・2水塩0.06w/v%、硫酸マグネシウム
・7水塩0.05w/v%、炭酸カルシウム0.3w/
v%及び水からなる液体培地を、500ml容三角フラ
スコに100mlずつ入れ、オートクレーブで121
℃、15分間滅菌し、冷却して、バチルス・スピーシー
ズ V230(FERM BP−5054)を接種し、
30℃、200rpmで20時間回転振盪培養したもの
を、種培養とした。<Experiment 1 Production of Enzyme> Sucrose 1.0 w / v
%, Polypeptone 0.5 w / v%, yeast extract 0.1 w
/ V%, dipotassium phosphate 0.1 w / v%, monosodium phosphate dihydrate 0.06 w / v%, magnesium sulfate heptahydrate 0.05 w / v%, calcium carbonate 0.3 w /
Liquid medium consisting of v% and water was placed in a 500 ml Erlenmeyer flask, 100 ml each, and the mixture was placed in an autoclave for 121
Sterilize at ℃ for 15 minutes, cool, inoculate with Bacillus species V230 (FERM BP-5054),
What was subjected to rotary shaking culture at 30 ° C. and 200 rpm for 20 hours was used as a seed culture.
【0039】容量10lのファーメンターに種培養の場
合と同組成の培地を約7l入れて、加熱滅菌、冷却して
温度30℃とした後、種培養液1v/v%を接種し、温
度30℃で、約20時間通気攪拌培養した。About 7 liters of a medium having the same composition as in the case of seed culture was placed in a fermenter having a volume of 10 liters, and the mixture was sterilized by heating and cooled to a temperature of 30 ° C., and 1 v / v% of a seed culture was inoculated at a temperature of 30 The culture was performed at 20 ° C. for about 20 hours with aeration and stirring.
【0040】培養液約6.5lを遠心分離(15,00
0G,20分間)して、培養液上清約6.3lを得た。
この培養液上清のβ−フラクトフラノシダーゼの活性
は、3.6単位/mlであった。About 6.5 l of the culture solution was centrifuged (15,000).
(0 G, 20 minutes) to obtain about 6.3 l of culture supernatant.
The β-fructofuranosidase activity of this culture supernatant was 3.6 units / ml.
【0041】〈実験2 酵素の精製〉実験1で得た培養
液上清に、飽和度0.8になるように硫安を加えて溶解
させ、4℃、一夜放置した後、遠心分離機にかけ、硫安
塩析物を回収した。<Experiment 2 Purification of Enzyme> Ammonium sulphate was added to the culture supernatant obtained in Experiment 1 to dissolve it at a saturation level of 0.8, allowed to stand at 4 ° C. overnight, and then centrifuged. The ammonium sulfate salted out product was recovered.
【0042】得られた硫安塩析物を、5mM塩化カルシ
ウムを含む10mM酢酸緩衝液(pH6.0)に溶解さ
せた後、同じ緩衝液に対して一昼夜透析し、遠心分離
(15,000G,20分間)して不溶物を除いた。そ
の透析液上清(210ml)を、DEAE−トヨパール
ゲル 650ゲル(東ソー株式会社製)を用いたイオン
交換カラムクロマトグラフィー(ゲル量380ml)に
かけた。The obtained ammonium sulfate salt precipitate was dissolved in 10 mM acetate buffer (pH 6.0) containing 5 mM calcium chloride, dialyzed against the same buffer for 24 hours and centrifuged (15,000 G, 20). The insoluble matter was removed for 1 minute). The dialysate supernatant (210 ml) was subjected to ion exchange column chromatography (gel amount 380 ml) using DEAE-Toyopearl gel 650 gel (manufactured by Tosoh Corporation).
【0043】本発明のβ−フラクトフラノシダーゼは、
上記DEAE−トヨパールゲルに吸着し、0.1M食塩
で溶出される画分に回収される。回収画分を1M硫安を
含む10mM酢酸緩衝液(pH6.0)に対して透析
し、その透析液を遠心分離(15,000G,20分
間)して不溶物を除き、次に、ブチルトヨパール 65
0ゲル(東ソー株式会社製)を用いた疎水カラムクロマ
トグラフィー(ゲル量100ml)を行った。吸着した
β−フラクトフラノシダーゼを硫安1Mから0Mへのリ
ニアグラジエントにより、カラムより溶出させ、酵素活
性画分を回収した。The β-fructofuranosidase of the present invention is
It is adsorbed to the DEAE-Toyopearl gel and collected in a fraction eluted with 0.1 M sodium chloride. The collected fraction was dialyzed against 10 mM acetate buffer (pH 6.0) containing 1 M ammonium sulfate, and the dialysate was centrifuged (15,000 G, 20 minutes) to remove insoluble matter, and then butyl toyopearl. 65
Hydrophobic column chromatography using 0 gel (manufactured by Tosoh Corporation) (gel amount 100 ml) was performed. The adsorbed β-fructofuranosidase was eluted from the column by a linear gradient from ammonium sulfate 1M to 0M, and the enzyme active fraction was collected.
【0044】続いて、DEAE−トヨパールゲル 65
0ゲルを用いたイオン交換カラムクロマトグラフィー
(ゲル量10ml)を行い、溶出した酵素活性画分を回
収した。Then, DEAE-Toyopearl gel 65
Ion exchange column chromatography using 0 gel (gel amount 10 ml) was performed, and the eluted enzyme active fraction was collected.
【0045】以上の精製手段により得られた精製酵素標
品における酵素活性の回収率は、培養液上清のそれに対
して約13%であった。また、精製酵素標品の比活性
は、蛋白質mg当たり205単位であった。なお、蛋白
質は、ローリー法に従って牛血清アルブミンを標準にし
て定量した。The recovery rate of enzyme activity in the purified enzyme preparation obtained by the above purification means was about 13% with respect to that of the culture supernatant. The specific activity of the purified enzyme preparation was 205 units per mg of protein. The protein was quantified according to the Lowry method using bovine serum albumin as a standard.
【0046】精製したβ−フラクトフラノシダーゼ標品
を、7.5w/v%濃度ポリアクリルアミドを含むゲル
電気泳動により酵素標品の純度を検定したところ、蛋白
バンドは単一で、純度の高い標品であった。The purified β-fructofuranosidase preparation was assayed for the purity of the enzyme preparation by gel electrophoresis containing 7.5 w / v% concentration polyacrylamide, and it was confirmed that the protein band was single and the purity was high. It was a product.
【0047】〈実験3 酵素の性質〉実験2の方法で得
た精製β−フラクトフラノシダーゼ標品を、SDS−ポ
リアクリルアミドゲル電気泳動法(ゲル濃度10w/v
%)に供し、同時に泳動した分子量マーカー(日本バイ
オ・ラッド ラボラトリーズ株式会社製)と比較して、
本酵素の分子量を測定したところ、分子量は49,00
0±5,000ダルトンであった。また、TSKgel
G3000SWカラム(φ7.8mm×300mm,
東ソー株式会社製)を用いたゲル濾過法により、分子量
を測定した結果、37,000±3,000ダルトンで
あった。<Experiment 3 Properties of enzyme> The purified β-fructofuranosidase preparation obtained by the method of Experiment 2 was subjected to SDS-polyacrylamide gel electrophoresis (gel concentration 10 w / v).
%), And compared with a molecular weight marker (manufactured by Nippon Bio-Rad Laboratories Co., Ltd.) that was electrophoresed at the same time,
When the molecular weight of this enzyme was measured, the molecular weight was 49.00
It was 0 ± 5,000 Daltons. Also, TSKgel
G3000SW column (φ7.8mm × 300mm,
As a result of measuring the molecular weight by a gel filtration method using Tosoh Corporation, the result was 37,000 ± 3,000 daltons.
【0048】上記と同じ精製β−フラクトフラノシダー
ゼ標品を、2w/v%アンフォライン(スウェーデン
国、ファルマシア・エルケイビー社製)含有等電点ポリ
アクリルアミドゲル電気泳動法に供し、泳動後、蛋白染
色およびゲルのpHを測定して、本酵素の等電点を求め
たところ、4.6±0.5であった。The same purified β-fructofuranosidase preparation as described above was subjected to isoelectric point polyacrylamide gel electrophoresis containing 2 w / v% ampholine (Pharmacia LKB, Sweden), and after electrophoresis, protein staining was performed. The pH of the gel was measured and the isoelectric point of this enzyme was determined to be 4.6 ± 0.5.
【0049】本発明のβ−フラクトフラノシダーゼ活性
に及ぼすpH、温度の影響を、5mM塩化カルシウム存
在下又は非存在下で、活性測定の方法に準じて調べた。
結果を、図1(pHの影響)及び図2(温度の影響)に
示した。本酵素の至適pHは、温度40℃、10分間反
応で、カルシウムイオン存在下、非存在下にかかわらず
pH約5.5乃至6.0、また、本酵素の至適温度は、
pH6.0、10分間反応で、カルシウムイオン存在下
で50℃付近、カルシウムイオン非存在下で45℃付近
であった。本酵素のpH安定性は、本酵素を各pHの5
0mM緩衝液中で4℃、24時間保持した後、pH6に
調整し、残存する酵素活性を測定することにより求め
た。また、熱安定性は、酵素溶液(20mM酢酸緩衝
液、pH6.0)を、各温度に1時間保持し、水冷した
後、残存する酵素活性を測定することにより求めた。結
果は、図3(pH安定性)及び図4(熱安定性)に示し
た。本酵素はpH約5.0乃至8.0の範囲で、また4
5℃付近まで安定であった。なお、本酵素のpH安定性
及び熱安定性は、カルシウムイオン存在下でも非存在下
と全く変わらなかった。また、本酵素活性は、1mMの
Cu++、Pb++、Fe++、Fe+++およびHg++で阻害
された。The effect of pH and temperature on the β-fructofuranosidase activity of the present invention was examined in the presence or absence of 5 mM calcium chloride according to the method for measuring activity.
The results are shown in FIG. 1 (effect of pH) and FIG. 2 (effect of temperature). The optimum pH of this enzyme is about 5.5 to 6.0 in the presence or absence of calcium ion at a temperature of 40 ° C. for 10 minutes, and the optimum temperature of this enzyme is
After reacting at pH 6.0 for 10 minutes, the temperature was around 50 ° C in the presence of calcium ions and around 45 ° C in the absence of calcium ions. The pH stability of this enzyme is 5
After keeping in 0 mM buffer at 4 ° C. for 24 hours, the pH was adjusted to 6 and the residual enzyme activity was measured. The thermal stability was determined by keeping the enzyme solution (20 mM acetate buffer, pH 6.0) at each temperature for 1 hour, cooling with water, and measuring the remaining enzyme activity. The results are shown in FIG. 3 (pH stability) and FIG. 4 (thermal stability). The enzyme has a pH range of about 5.0 to 8.0 and 4
It was stable up to around 5 ° C. The pH stability and heat stability of this enzyme were completely the same in the presence of calcium ions as in the absence thereof. Moreover, this enzyme activity was inhibited by 1 mM of Cu ++ , Pb ++ , Fe ++ , Fe +++ and Hg ++ .
【0050】〈実験4 基質特異性〉最終濃度2w/v
%の蔗糖、ラフィノース、エルロース、スタキオース、
ラクトスクロース、キシロシルフラクトシド、マルトー
ス、セロビオース、乳糖、イヌリンあるいはレバンに、
実験2の方法で得た精製β−フラクトフラノシダーゼを
基質固形物1グラム当たり2単位ずつ加え、40℃、p
H5.5で24時間作用させた。酵素反応前後の反応液
をキーゼルゲル60(メルク社製;アルミプレート,2
0×20cm)を用いた薄層クロマトグラフィー(以
下、「TLC」と略称する。)を行い、それぞれの糖質
に対する酵素作用の有無を確認した。TLCは、展開溶
媒に1−ブタノール:ピリジン:水=7:3:1(容積
比)を用い、室温で1回展開した。発色は、フラクトー
スを構成糖として含む基質の場合は、0.2w/v%ナ
フトレゾルシノール−0.5Nリン酸溶液を噴霧し、1
10℃で約5分間加熱して行い、それ以外の基質の場合
は、20w/v%硫酸−メタノール溶液を噴霧し、11
0℃で約10分間加熱して行った。<Experiment 4 Substrate specificity> Final concentration 2 w / v
% Sucrose, raffinose, erulose, stachyose,
For lactosucrose, xylosylfructoside, maltose, cellobiose, lactose, inulin or levan,
Purified β-fructofuranosidase obtained by the method of Experiment 2 was added in 2 units per gram of substrate solid, and the mixture was added at 40 ° C. and p
It was operated at H5.5 for 24 hours. Kieselgel 60 (manufactured by Merck & Co .; aluminum plate, 2)
Thin layer chromatography (0 × 20 cm) (hereinafter, abbreviated as “TLC”) was performed to confirm the presence or absence of an enzymatic action on each sugar. The TLC was developed once at room temperature using 1-butanol: pyridine: water = 7: 3: 1 (volume ratio) as a developing solvent. For the color development, in the case of a substrate containing fructose as a constituent sugar, 0.2 w / v% naphthresorcinol-0.5N phosphoric acid solution was sprayed to
Heating is performed at 10 ° C. for about 5 minutes, and for other substrates, 20 w / v% sulfuric acid-methanol solution is sprayed.
The heating was performed at 0 ° C. for about 10 minutes.
【0051】その結果、本発明のβ−フラクトフラノシ
ダーゼは、蔗糖、ラフィノース、エルロース、スタキオ
ース、ラクトスクロース、キシロシルフラクトシドに作
用して、フラクトースを特異的に遊離し、マルトース、
セロビオース、乳糖、イヌリン、レバンには、作用しな
いことが判明した。As a result, the β-fructofuranosidase of the present invention acts on sucrose, raffinose, erulose, stachyose, lactosucrose and xylosylfructoside to specifically release fructose, maltose,
It was found to have no effect on cellobiose, lactose, inulin, and levan.
【0052】〈実験5 受容体特異性〉受容体として表
1に示す各種単糖類、オリゴ糖類及びアルコール類と、
供与体として蔗糖とを、重量比で等量混合した最終濃度
10%の糖液に、実験2の方法で得た精製β−フラクト
フラノシダーゼを、蔗糖1グラム当たり2単位ずつ加
え、40℃、pH5.5で24時間作用させた。酵素反
応前後の反応液を、実験4と同様にTLCを行い、0.
2w/v%ナフトレゾルシノール−0.5Nリン酸溶液
を噴霧し、110℃で約5分間加熱して発色させ、転移
糖を生成しているかどうかを判定した。結果を、表1に
示した。<Experiment 5 Receptor Specificity> Various monosaccharides, oligosaccharides and alcohols shown in Table 1 as receptors,
To the sugar solution having a final concentration of 10%, which was obtained by mixing equal amounts of sucrose as a donor in a weight ratio, the purified β-fructofuranosidase obtained by the method of Experiment 2 was added in 2 units per 1 gram of sucrose, and 40 ° C. It was allowed to act at pH 5.5 for 24 hours. The reaction solution before and after the enzyme reaction was subjected to TLC in the same manner as in Experiment 4 to give 0.
A 2 w / v% naphthresorcinol-0.5N phosphoric acid solution was sprayed and heated at 110 ° C. for about 5 minutes to cause color development, and it was determined whether or not a transfer sugar was produced. The results are shown in Table 1.
【0053】[0053]
【表1】 [Table 1]
【0054】表1に示されるように、本発明のβ−フラ
クトフラノシダーゼは、蔗糖を糖供与体として、D−キ
シロース、D−ガラクトース、マルトース、イソマルト
ース、セロビオース、マルトトリオース、パノース、乳
糖、メリビオースなどの還元性糖質、トレハロースなど
の非還元性糖質にフラクトシル基を良く転移することが
判明した。また、D−キシリトール、D−ソルビトー
ル、マルチトールなどの糖アルコール類及びグリセロー
ル、エチレングリコールなどのアルコール類にも良く転
移し、フラクトシル転移糖を生成することが判った。As shown in Table 1, the β-fructofuranosidase of the present invention uses D-xylose, D-galactose, maltose, isomaltose, cellobiose, maltotriose, panose, lactose with sucrose as a sugar donor. , It was found that the fructosyl group was transferred well to reducing sugars such as melibiose and non-reducing sugars such as trehalose. In addition, it was found that it is well transferred to sugar alcohols such as D-xylitol, D-sorbitol and maltitol and alcohols such as glycerol and ethylene glycol to produce fructosyl transfer sugar.
【0055】〈実験6 蔗糖と還元性糖質とからのフラ
クトシル転移糖〉本発明のβ−フラクトフラノシダーゼ
による糖転移反応で生成するフラクトシル転移糖を同定
するために、確認試験を行った。実験5で得た蔗糖と乳
糖とを基質とした酵素反応液の一部を、糖濃度2%にな
るよう20mM酢酸緩衝液(pH4.5)で希釈し、こ
の0.5mlにインベルターゼ(生化学工業株式会社
製)0.1単位、又はβ−ガラクトシダーゼ(生化学工
業株式会社製)0.1単位を加え、40℃で20時間反
応させた。本発明のβ−フラクトフラノシダーゼによる
反応液、そのインベルターゼ処理液及びβ−ガラクトシ
ダーゼ処理液の糖成分をガスクロマトグラフィー(以
下、「GLC」と略称する。)で分析した。酵素反応液
の一部を乾固し、ピリジンに溶解した後、トリメチルシ
リル化したものをGLCの分析試料とした。GLCカラ
ムは、2%シリコンOV−17/クロモゾルブW(ジー
・エル・サイエンス株式会社製)を充填したステンレス
カラム(3mmφ×2m)、キャリアーガスは、窒素ガ
スを流量40ml/分で、カラムオーブン温度は、16
0℃から320℃まで7.5℃/分の昇温速度で分析し
た。検出は、水素炎イオン化検出器を用いた。<Experiment 6 Fructosyl-transferring sugar from sucrose and reducing sugar> A confirmatory test was carried out to identify a fructosyl-transferring sugar produced in the transglycosylation reaction by the β-fructofuranosidase of the present invention. A part of the enzyme reaction solution using sucrose and lactose as the substrates obtained in Experiment 5 was diluted with 20 mM acetate buffer (pH 4.5) to a sugar concentration of 2%, and 0.5 ml of this was used for invertase (biochemical 0.1 unit (manufactured by Kogyo Co., Ltd.) or 0.1 unit of β-galactosidase (manufactured by Seikagaku Co., Ltd.) was added and reacted at 40 ° C. for 20 hours. The reaction liquid with the β-fructofuranosidase of the present invention, the invertase-treated liquid and the sugar component of the β-galactosidase-treated liquid were analyzed by gas chromatography (hereinafter, abbreviated as “GLC”). A part of the enzyme reaction solution was dried, dissolved in pyridine, and then trimethylsilylated to obtain a GLC analysis sample. The GLC column is a stainless steel column (3 mmφ × 2 m) packed with 2% silicon OV-17 / Chromozorb W (manufactured by GL Science Co., Ltd.), and the carrier gas is nitrogen gas at a flow rate of 40 ml / min and the column oven temperature. Is 16
The analysis was performed from 0 ° C. to 320 ° C. at a heating rate of 7.5 ° C./min. A flame ionization detector was used for detection.
【0056】その結果、本発明のβ−フラクトフラノシ
ダーゼによる蔗糖と乳糖とからのフラクトシル転移糖の
ピークの保持時間は、既知糖質ラクトスクロース(ラク
トシルフラクトシド)のそれと一致し、インベルターゼ
処理、あるいはβ−ガラクトシダーゼ処理により、その
ピークは消失し、それぞれフラクトースと乳糖、ガラク
トースと蔗糖に分解されることが判った。インベルター
ゼ及びβ−ガラクトシダーゼの反応特性を考慮すると、
本発明のβ−フラクトフラノシダーゼによる蔗糖と乳糖
とからのフラクトシル転移生成物は、ラクトスクロース
であると判断される。As a result, the retention time of the peak of the fructosyl-transferred sugar from sucrose and lactose by the β-fructofuranosidase of the present invention was in agreement with that of the known sugar lactosucrose (lactosylfructoside), and the invertase treatment, Alternatively, it was found that the peaks disappeared by β-galactosidase treatment and they were decomposed into fructose and lactose, and galactose and sucrose, respectively. Considering the reaction characteristics of invertase and β-galactosidase,
The fructosyl transfer product from sucrose and lactose by the β-fructofuranosidase of the present invention is considered to be lactosucrose.
【0057】キシロース、マルトース、イソマルトース
を受容体として生成したフラクトシル転移糖の場合も、
インベルターゼ処理前後の反応液のGLC分析の結果、
及び既知糖質のGLC分析との比較結果から、それぞれ
キシロシルフラクトシド、エルロース(マルトシルフラ
クトシド)、イソマルトシルフラクトシドであることが
判った。本発明のβ−フラクトフラノシダーゼによる糖
転移反応において、これら還元性糖質を受容体とした場
合のフラクトシル転移糖は、受容体としての還元性糖質
残基における1位炭素原子にβ−フラクトフラノシド結
合しているものと判断される。In the case of a fructosyl-transferring saccharide produced by using xylose, maltose or isomaltose as an acceptor,
As a result of GLC analysis of the reaction solution before and after the invertase treatment,
From the results of comparison with GLC analysis of known sugars, it was found that they were xylosylfructoside, erulose (maltosylfructoside) and isomaltosylfructoside, respectively. In the transglycosylation reaction by the β-fructofuranosidase of the present invention, when these reducing sugars are used as acceptors, the fructosyl-transferring sugars have β-fructo at the 1-position carbon atom in the reducing sugar residue as the acceptor. It is considered to be a furanoside bond.
【0058】〈実験7 フラクトシルトレハロース〉一
方、トレハロースへのフラクトシル転移糖の構造を調べ
るため、フラクトシルトレハロースを単離し、構造を調
べた。蔗糖及びトレハロースをそれぞれ20%含む糖液
をpH6.0に調整し、これに実験2の方法で得た精製
β−フラクトフラノシダーゼを蔗糖1グラム当たり4単
位加え、55℃で20時間反応させ、次いで100℃で
10分間加熱して酵素を失活させた。本溶液には、フラ
クトシルトレハロースを約23%含有していた。本溶液
を活性炭で脱色、濾過し、H型及びOH型イオン交換樹
脂により脱塩して精製し、濃度約50%まで濃縮して、
カラムクロマトグラフィーを行ない、フラクトシルトレ
ハロース高含有画分を採取した。<Experiment 7 Fructosyltrehalose> On the other hand, in order to investigate the structure of the saccharide transferred to trehalose, fructosyltrehalose was isolated and its structure was investigated. A sugar solution containing 20% each of sucrose and trehalose was adjusted to pH 6.0, and 4 units of the purified β-fructofuranosidase obtained by the method of Experiment 2 was added thereto per 1 gram of sucrose, and the mixture was reacted at 55 ° C. for 20 hours, Then, the enzyme was inactivated by heating at 100 ° C. for 10 minutes. This solution contained about 23% fructosyl trehalose. This solution is decolorized with activated carbon, filtered, desalted with H-type and OH-type ion exchange resins for purification, and concentrated to a concentration of about 50%,
Column chromatography was performed to collect a fraction containing a large amount of fructosyltrehalose.
【0059】分画用樹脂は、アルカリ金属型強酸性カチ
オン交換樹脂(東京有機化学工業株式会社製、商品名
『XT−1016』、Na型、架橋度4%)を使用し、
内径3cm、長さ1mのジャケット付きステンレス製カ
ラム2本に水懸濁状で充填し、直列につなぎ、樹脂層全
長を約2mになるようにした。カラム内温度を40℃に
維持しつつ、糖液を樹脂に対して5v/v%加え、これ
に40℃の温水をSV0.15の流速で流して分画し、
フラクトシルトレハロース高含有画分を採取した。As the fractionation resin, an alkali metal type strongly acidic cation exchange resin (manufactured by Tokyo Organic Chemical Industry Co., Ltd., trade name "XT-1016", Na type, crosslinking degree 4%) is used.
Two stainless steel columns with a jacket having an inner diameter of 3 cm and a length of 1 m were packed in a water suspension form and connected in series so that the total length of the resin layer was about 2 m. While maintaining the temperature in the column at 40 ° C., a sugar solution was added at 5 v / v% to the resin, and hot water at 40 ° C. was flowed at a flow rate of SV 0.15 to fractionate,
Fractions high in fructosyl trehalose were collected.
【0060】フラクトシルトレハロース高含有画分を脱
塩、精製し、濃度約40%に濃縮してオクタデシルシリ
カゲルを充填したカラム(株式会社ワイエムシー、商品
名『YMC−Pack ODS』)を用いたクロマトグ
ラフィーを行ない、フラクトシルトレハロース高含有画
分を採取した。この方法を繰り返して採取されたフラク
トシルトレハロース高含有液を脱塩、精製、濃縮、真空
乾燥して、フラクトシルトレハロース高含有粉末を固形
物収率約10%で得た。本粉末標品は、フラクトシルト
レハロースを固形物当たり約98%含有していた。Fractions high in fructosyltrehalose were desalted, purified, concentrated to a concentration of about 40%, and chromatographed using a column packed with octadecyl silica gel (YMC, trade name "YMC-Pack ODS"). The fraction was enriched in fructosyl trehalose and collected. The fructosyl trehalose-rich liquid collected by repeating this method was desalted, purified, concentrated and vacuum dried to obtain a fructosyl trehalose-rich powder at a solid yield of about 10%. This powder preparation contained fructosyl trehalose in an amount of about 98% based on the solid content.
【0061】フラクトシルトレハロース高含有粉末標品
を用いて、酵素法及び部分メチルヘキシトールアセテー
トのGLC分析により構造を確認した。その結果、本発
明のβ−フラクトフラノシダーゼの作用により生成する
フラクトシルトレハロースは、インベルターゼ処理によ
り1対1のモル比でフラクトースとトレハロースとに分
解されること、及び、本糖質をメチル化した後、酸によ
り加水分解し、続いて還元、アセチル化して得られた部
分メチルヘキシトールアセテートをGLCで分析する
と、1,5,6−トリ−O−アセチル−2,3,4−ト
リ−O−メチルグルシトールと1,5−ジ−O−アセチ
ル−2,3,4,6−テトラ−O−メチルグルシトール
が等モル比で検出されることから、トレハロースにフラ
クトシル基がβ−2,6結合した3糖であることが判明
した。The structure was confirmed by an enzymatic method and GLC analysis of partial methylhexitol acetate using a powdered preparation containing a large amount of fructosyltrehalose. As a result, fructosyltrehalose produced by the action of β-fructofuranosidase of the present invention was decomposed into fructose and trehalose at a molar ratio of 1: 1 by invertase treatment, and the sugar was methylated. After partial hydrolysis with acid, and subsequent reduction and acetylation, partial methylhexitol acetate obtained was analyzed by GLC to find that it was 1,5,6-tri-O-acetyl-2,3,4-tri-. Since O-methylglucitol and 1,5-di-O-acetyl-2,3,4,6-tetra-O-methylglucitol were detected at an equimolar ratio, trehalose contained β-fructosyl groups. It was found to be a trisaccharide linked by -2,6.
【0062】〈実験8 急性毒性〉7週齢のdd系マウ
スを使用して、後述する実施例A−4の方法で調製した
ラクトスクロース高含有粉末を、経口投与して急性毒性
テストをしたところ、体重1kg当たり15gまで死亡
例は見られず、これ以上の投与は困難であった。従っ
て、本糖質の毒性は極めて低い。また、同様に、7週齢
のdd系マウスを使用して、それぞれ後述する実施例A
−6の方法で得たエルロース高含有粉末、実施例A−8
の方法で得たキシロシルフラクトシド高含有シラップ、
実施例A−11の方法で得たフラクトシルトレハロース
高含有粉末及び実施例A−12の方法で得たイソマルト
シルフラクトシド含有シラップを用いて、経口投与によ
り急性毒性テストをしたところ、いずれも、体重1kg
当たり15gまで死亡例は見られず、これ以上の投与は
困難であった。従って、これら糖質の毒性は極めて低
い。<Experiment 8 Acute Toxicity> A lactosucrose-rich powder prepared by the method of Example A-4 described below was orally administered to a 7-week-old dd mouse to perform an acute toxicity test. No fatal cases were observed up to 15 g per 1 kg of body weight, and further administration was difficult. Therefore, the toxicity of this carbohydrate is extremely low. Similarly, using 7-week-old dd strain mice, Example A described later, respectively.
Powder containing a high amount of erulose obtained by the method of Example -6, Example A-8
Xylopylfructoside-rich syrup obtained by the method of
An acute toxicity test was conducted by oral administration using the fructosyltrehalose-rich powder obtained by the method of Example A-11 and the isomaltosylfructoside-containing syrup obtained by the method of Example A-12. , Weight 1kg
No deaths were seen up to 15 g, and further administration was difficult. Therefore, the toxicity of these carbohydrates is extremely low.
【0063】以下、本発明のβ−フラクトフラノシダー
ゼと、それを利用したフラクトシル転移糖含有糖質の製
造方法を実施例Aで、このフラクトシル転移糖含有糖質
を含有せしめた組成物を実施例Bで示す。The β-fructofuranosidase of the present invention and a method for producing a fructosyl-transferring sugar-containing sugar using the same are described in Example A, and a composition containing the fructosyl-transferring sugar-containing sugar is described in Example. Shown as B.
【0064】〈実施例A−1〉バチルス・スピーシーズ
V230(FERM BP−5054)を、培地組成
中の蔗糖濃度を2w/v%とし、容量30lのファーメ
ンターを用いて、培地液量を約20lとした以外は、実
験1と同じ方法で約24時間、通気攪拌培養した。この
培養上清のβ−フラクトフラノシダーゼ活性は、培養液
1ml当たり7.3単位であった。培養液をMF膜濾過
し、その透過液をUF膜濃縮して、ml当たりβ−フラ
クトフラノシダーゼ活性約130単位を有する酵素液
を、もとの培養液の総活性に対して約80%の収率で得
た。Example A-1 Bacillus species V230 (FERM BP-5054) was used with a sucrose concentration of 2 w / v% in the medium composition and a medium volume of about 20 l using a fermenter with a volume of 30 l. Except for the above, the culture was performed with aeration and stirring for about 24 hours in the same manner as in Experiment 1. The β-fructofuranosidase activity of this culture supernatant was 7.3 units per 1 ml of the culture medium. The culture solution was subjected to MF membrane filtration, and the permeate was subjected to UF membrane concentration to obtain an enzyme solution having about 130 units of β-fructofuranosidase activity per ml of about 80% of the total activity of the original culture solution. Obtained in yield.
【0065】〈実施例A−2〉蔗糖及び乳糖をそれぞれ
20%含む水溶液をpH5.5に調整し、これに実施例
A−1の方法で調製したβ−フラクトフラノシダーゼ
を、蔗糖1グラム当たり1単位の割合になるように加
え、55℃で16時間反応させた。その反応液を90℃
で30分間加熱し、酵素を失活させた後、冷却し、常法
に従って活性炭で脱色、濾過し、H型及びOH型イオン
交換樹脂により脱塩して精製し、更に濃縮して、濃度約
75%のシラップを固形物収率約95%で得た。<Example A-2> An aqueous solution containing 20% each of sucrose and lactose was adjusted to pH 5.5, and β-fructofuranosidase prepared by the method of Example A-1 was added thereto per gram of sucrose. It was added so that the ratio was 1 unit and reacted at 55 ° C. for 16 hours. 90 ° C
After heating for 30 minutes at 37 ° C to inactivate the enzyme, it is cooled, decolorized with activated carbon according to a conventional method, filtered, desalted with H-type and OH-type ion exchange resins for purification, and further concentrated to a concentration of about 75% syrup was obtained with a solids yield of about 95%.
【0066】本品は、固形物当たりラクトスクロースを
約37%含有しており、味質良好な甘味、適度の粘度、
保湿性を有し、甘味剤、呈味改良剤、安定剤、賦形剤、
ビフィズス菌増殖促進剤、ミネラル吸収促進剤などとし
て飲食物、化粧品、医薬品など各種組成物に有利に利用
できる。This product contains about 37% lactosucrose per solid matter, has a good taste, sweetness, moderate viscosity, and
Has moisturizing properties, sweeteners, taste improvers, stabilizers, excipients,
It can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals as a bifidobacteria growth promoter, mineral absorption promoter and the like.
【0067】〈実施例A−3〉蔗糖を22%及び乳糖を
18%含む水溶液をpH6.0に調整し、これに実施例
A−1で調製したβ−フラクトフラノシダーゼを、蔗糖
1グラム当たり1単位、及びインベルターゼ欠損酵母を
固形物重量当たり湿重量で5%になるように加えて、1
規定の水酸化ナトリウム溶液を用いて該反応液をpH6
乃至7に制御しながら、35℃で20時間反応させた。
その反応液を90℃で30分間加熱し、酵素を失活させ
た後、冷却し、常法に従って活性炭で脱色、濾過し、H
型及びOH型イオン交換樹脂により脱塩して精製し、更
に濃縮して濃度約75%のシラップを固形物収率約70
%で得た。Example A-3 An aqueous solution containing 22% sucrose and 18% lactose was adjusted to pH 6.0, and the β-fructofuranosidase prepared in Example A-1 was added thereto per gram of sucrose. 1 unit, and invertase-deficient yeast were added so as to be 5% by wet weight per solid weight, and 1
The reaction solution was adjusted to pH 6 with a specified sodium hydroxide solution.
The reaction was carried out at 35 ° C. for 20 hours while controlling to 7 to 7.
The reaction solution was heated at 90 ° C. for 30 minutes to inactivate the enzyme, then cooled, decolorized with activated carbon according to a conventional method, filtered, and
And OH type ion exchange resin for desalination and purification, and further concentration to obtain a syrup having a concentration of about 75% in a solid yield of about 70.
%.
【0068】本品は、固形物当たりラクトスクロースを
約65%含有しており、味質良好な甘味、適度の粘度、
保湿性を有し、甘味剤、呈味改良剤、安定剤、ビフィズ
ス菌増殖促進剤、ミネラル吸収促進剤などとして飲食
物、化粧品、医薬品など各種組成物に有利に利用でき
る。This product contains about 65% lactosucrose per solid matter, and has a good taste, sweetness, moderate viscosity, and
It has a moisturizing property and can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals as a sweetener, a taste improver, a stabilizer, a bifidobacteria growth promoter, a mineral absorption promoter and the like.
【0069】〈実施例A−4〉実施例A−2の方法で反
応、精製した固形物当たり約37%のラクトスクロース
含有溶液を原料糖液とし、これを濃縮して濃度約45%
にした。本糖液のラクトスクロース含量を高めるため、
アルカリ金属型強酸性カチオン交換樹脂(東京有機化学
工業株式会社製、商品名『XT−1016』、Na型、
架橋度4%)を用いたカラムクロマトグラフィーを行っ
た。樹脂を内径5.4cmのジャケット付きステンレス
製カラム4本に充填し、直列につなぎ、樹脂層全長20
mとした。カラム内温度を40℃に維持しつつ、糖液を
樹脂に対して5v/v%加え、これに40℃の温水をS
V0.2の流速で流して分画し、ラクトスクロース高含
有画分を採取した。更に、精製、濃縮し、真空乾燥し、
粉砕して、ラクトスクロース高含有粉末を固形物収率約
30%で得た。Example A-4 A solution containing lactosucrose of about 37% based on the solid substance reacted and purified by the method of Example A-2 was used as a raw sugar solution, which was concentrated to a concentration of about 45%.
I made it. To increase the lactosucrose content of this sugar solution,
Alkali metal strong acid cation exchange resin (Tokyo Organic Chemical Industry Co., Ltd., trade name "XT-1016", Na type,
Column chromatography was performed using a crosslinking degree of 4%). Resin was packed in four stainless steel columns with an inner diameter of 5.4 cm and which were connected in series to form a resin layer with a total length of 20
m. While maintaining the temperature in the column at 40 ° C, 5v / v% of sugar solution was added to the resin, and warm water at 40 ° C was added to the solution.
Fractionation was carried out at a flow rate of V0.2, and a lactosucrose-rich fraction was collected. Further purification, concentration, vacuum drying,
Grinding gave a lactosucrose-rich powder with a solids yield of about 30%.
【0070】本品は、固形物当たり約90%のラクトス
クロースを含有しており、低い還元性、味質良好な甘
味、保湿性、低う蝕性を有し、甘味剤、呈味改良剤、安
定剤、賦形剤、ビフィズス菌増殖促進剤、ミネラル吸収
促進剤などとして飲食物、化粧品、医薬品など各種組成
物に有利に利用できる。This product contains about 90% lactosucrose per solid and has low reducing property, good sweetness, sweetness, moisturizing property and low caries property, and is a sweetener and taste improver. , Stabilizers, excipients, bifidobacteria growth promoters, mineral absorption promoters, etc. can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals.
【0071】〈実施例A−5〉蔗糖及びマルトースをそ
れぞれ20%含む糖液をpH5.5に調整し、これに実
施例A−1の方法で調製したβ−フラクトフラノシダー
ゼを、蔗糖1グラム当たり1単位の割合になるように加
え、50℃で24時間反応させた。その反応液を90℃
で30分間加熱し、酵素を失活させた後、冷却し、常法
に従って活性炭で脱色、濾過し、H型及びOH型イオン
交換樹脂により脱塩して精製し、更に濃縮して濃度約7
5%のシラップを固形物収率約95%で得た。Example A-5 A sugar solution containing 20% each of sucrose and maltose was adjusted to pH 5.5, and β-fructofuranosidase prepared by the method of Example A-1 was added to 1 g of sucrose. 1 unit per unit, and reacted at 50 ° C. for 24 hours. 90 ° C
For 30 minutes to deactivate the enzyme, then cooled, decolorized with activated carbon according to a conventional method, filtered, purified by desalting with H-type and OH-type ion exchange resins, and further concentrated to a concentration of about 7%.
5% syrup was obtained with a solids yield of about 95%.
【0072】本品は、固形物当たりエルロースを約28
%含有しており、味質良好な甘味、適度な粘度、保湿性
を有し、飲食物、化粧品、医薬品など各種組成物に有利
に利用できる。This product contains about 28% erulose per solid.
%, It has a good taste, sweetness, moderate viscosity, and moisturizing property, and can be advantageously used for various compositions such as food and drink, cosmetics, and pharmaceuticals.
【0073】〈実施例A−6〉実施例A−5の方法で反
応、精製した固形物当たり約28%のエルロース含有溶
液を原料糖液とし、これを濃縮して濃度約45%にし
た。本糖液のエルロース含量を高めるため、分画用樹脂
として、アルカリ金属型強酸性カチオン交換樹脂(ダウ
ケミカル社販売、商品名『ダウエックス50W×4』、
Ca型)を用いた以外は、実施例A−4の方法に従って
カラムクロマトグラフィーを行ない、エルロース高含有
画分を採集した。更に、精製、濃縮し、真空乾燥し、粉
砕して、エルロース高含有粉末を固形物収率約25%で
得た。Example A-6 A solution containing about 28% erulose per solid matter reacted and purified by the method of Example A-5 was used as a raw sugar solution and concentrated to a concentration of about 45%. In order to increase the ellulose content of this sugar solution, as a fractionation resin, an alkali metal type strongly acidic cation exchange resin (sold by Dow Chemical Co., trade name “Dowex 50W × 4”,
Column chromatography was carried out according to the method of Example A-4 except that Ca type) was used, and a fraction containing high erulose was collected. Further purification, concentration, vacuum drying and crushing gave a powder with a high erulose content in a solids yield of about 25%.
【0074】本品は、固形物当たり約84%のエルロー
スを含有しており、低い還元性、味質良好な甘味、保湿
性、低う蝕性を有し、飲食物、化粧品、医薬品など各種
組成物に有利に利用できる。This product contains about 84% erulose per solid matter and has a low reducing property, a good taste sweetness, a moisturizing property and a low caries property, and can be used for various foods, cosmetics, pharmaceuticals and the like. It can be advantageously used in a composition.
【0075】〈実施例A−7〉蔗糖を30%及びキシロ
ースを15%含む糖液をpH5.5に調整し、これに実
施例A−1の方法で調製したβ−フラクトフラノシダー
ゼを、蔗糖1グラム当たり0.5単位の割合になるよう
に加え、50℃で40時間反応させた。その反応液を9
0℃で30分間加熱し、酵素を失活させた後、冷却し、
常法に従って活性炭で脱色、濾過し、H型及びOH型イ
オン交換樹脂により脱塩して精製し、更に濃縮して濃度
約75%のシラップを固形物収率約95%で得た。Example A-7 A sugar solution containing 30% sucrose and 15% xylose was adjusted to pH 5.5, and β-fructofuranosidase prepared by the method of Example A-1 was added to the sucrose solution. It was added at a rate of 0.5 unit per gram and reacted at 50 ° C. for 40 hours. 9
Heat at 0 ° C. for 30 minutes to inactivate the enzyme, then cool,
According to a conventional method, decolorization with activated carbon, filtration, desalting with H-type and OH-type ion exchange resins for purification, and further concentration were carried out to obtain syrup having a concentration of about 75% with a solid yield of about 95%.
【0076】本品は、固形物当たりキシロシルフラクト
シドを約35%含有しており、味質良好な甘味、適度な
粘度、保湿性、低う蝕性を有し、甘味剤、呈味改良剤、
安定剤、ビフィズス菌増殖促進剤、ミネラル吸収促進剤
などとして飲食物、化粧品、医薬品など各種組成物に有
利に利用できる。This product contains about 35% of xylosylfructoside per solid matter, has a good taste sweetness, moderate viscosity, moisturizing property and low cariogenicity, and is a sweetener and taste improver. Agent,
It can be advantageously used in various compositions such as foods and drinks, cosmetics and pharmaceuticals as a stabilizer, a bifidobacteria growth promoter, a mineral absorption promoter and the like.
【0077】〈実施例A−8〉蔗糖を30%及びキシロ
ースを15%含む糖液をpH6.0に調整し、これに実
施例A−1で調製したβ−フラクトフラノシダーゼを、
蔗糖1グラム当たり0.5単位の割合になるように加
え、50℃で40時間反応させた。その反応液に水酸化
ナトリウムを加えてpH10以上のアルカリ性に保ちな
がら100℃で加熱した後、冷却し、常法に従って活性
炭で脱色、濾過し、H型及びOH型イオン交換樹脂によ
り脱塩して精製し、更に濃縮して濃度約75%のシラッ
プを固形物収率約55%で得た。Example A-8 A sugar solution containing 30% sucrose and 15% xylose was adjusted to pH 6.0, and the β-fructofuranosidase prepared in Example A-1 was added thereto.
It was added at a ratio of 0.5 unit per gram of sucrose and reacted at 50 ° C. for 40 hours. Sodium hydroxide was added to the reaction solution, and the mixture was heated at 100 ° C. while keeping it alkaline at pH 10 or higher, then cooled, decolorized with activated carbon according to a conventional method, filtered, and desalted with H-type and OH-type ion exchange resins. Purification and further concentration gave syrup with a concentration of about 75% with a solids yield of about 55%.
【0078】本品は、固形物当たりキシロシルフラクト
シドを約60%含有しており、味質良好な甘味、適度な
粘度、保湿性を有し、甘味剤、呈味改良剤、安定剤、ビ
フィズス菌増殖促進剤、ミネラル吸収促進剤などとして
飲食物、化粧品、医薬品など各種組成物に有利に利用で
きる。This product contains about 60% of xylosylfructoside per solid matter, has a sweetness with a good taste, an appropriate viscosity and a moisturizing property, and is a sweetener, a taste improver, a stabilizer, It can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals as a bifidobacteria growth promoter, mineral absorption promoter and the like.
【0079】〈実施例A−9〉蔗糖及びトレハロースを
それぞれ20%含む糖液をpH5.5に調整し、これに
実施例A−1の方法で調製したβ−フラクトフラノシダ
ーゼを、蔗糖1グラム当たり4単位の割合になるように
加え、55℃で16時間反応させた。その反応液を90
℃で30分間加熱し、酵素を失活させた後、冷却し、常
法に従って活性炭で脱色、濾過し、H型及びOH型イオ
ン交換樹脂により脱塩して精製し、更に濃縮して濃度約
75%のシラップを固形物収率約95%で得た。Example A-9 A sugar solution containing 20% each of sucrose and trehalose was adjusted to pH 5.5, and 1 g of sucrose was prepared using β-fructofuranosidase prepared by the method of Example A-1. It was added so as to be a ratio of 4 units per 1 hour, and reacted at 55 ° C. for 16 hours. 90 times the reaction solution
After heating at ℃ for 30 minutes to inactivate the enzyme, it is cooled, decolorized with activated carbon according to the usual method, filtered, desalted with H-type and OH-type ion exchange resins for purification, and further concentrated to a concentration of about 75% syrup was obtained with a solids yield of about 95%.
【0080】本品は、固形物当たりフラクトシルトレハ
ロースを約24%含有しており、味質良好な甘味、適度
な粘度、保湿性、低う蝕性を有し、甘味剤、呈味改良
剤、安定剤、ビフィズス菌増殖促進剤、ミネラル吸収促
進剤などとして飲食物、化粧品、医薬品など各種組成物
に有利に利用できる。This product contains about 24% of fructosyl trehalose per solid substance, has a good taste sweetness, moderate viscosity, moisturizing property and low caries property, and is a sweetener and taste improver. , Stabilizers, bifidobacteria growth promoters, mineral absorption promoters, etc. can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals.
【0081】〈実施例A−10〉蔗糖及びトレハロース
をそれぞれ20%含む糖液をpH5.5に調整し、これ
に実施例A−1で調製したβ−フラクトフラノシダーゼ
を、蔗糖1グラム当たり4単位、及びインベルターゼ欠
損酵母を固形物重量当たり湿重量で5%になるように加
えて、1規定の水酸化ナトリウム溶液を用いて該反応液
をpH6乃至7に制御しながら、35℃で20時間反応
させた。その反応液を90℃で30分間加熱し、酵素を
失活させた後、冷却し、常法に従って活性炭で脱色、濾
過し、H型及びOH型イオン交換樹脂により脱塩して精
製し、更に濃縮して濃度約75%のシラップを固形物収
率約70%で得た。Example A-10 A sugar solution containing 20% each of sucrose and trehalose was adjusted to pH 5.5, and the β-fructofuranosidase prepared in Example A-1 was added thereto at 4% per gram of sucrose. Units and invertase-deficient yeast are added so as to be 5% in terms of wet weight per solid weight, and the reaction solution is adjusted to pH 6 to 7 with 1N sodium hydroxide solution, and at 35 ° C. for 20 hours. It was made to react. The reaction solution was heated at 90 ° C. for 30 minutes to deactivate the enzyme, then cooled, decolorized with activated carbon according to a conventional method, filtered, desalted with H-type and OH-type ion exchange resins, and further purified. Concentration gave syrup with a concentration of about 75% with a solids yield of about 70%.
【0082】本品は、固形物当たりフラクトシルトレハ
ロースを約34%含有しており、味質良好な甘味、適度
な粘度、保湿性を有し、甘味剤、呈味改良剤、安定剤、
ビフィズス菌増殖促進剤、ミネラル吸収促進剤などとし
て飲食物、化粧品、医薬品など各種組成物に有利に利用
できる。This product contains about 34% of fructosyl trehalose per solid matter, has a good taste sweetness, an appropriate viscosity and a moisturizing property, and has a sweetener, a taste improver, a stabilizer,
It can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals as a bifidobacteria growth promoter, mineral absorption promoter and the like.
【0083】〈実施例A−11〉実施例A−9の方法で
反応、精製した固形物当たり約24%のフラクトシルト
レハロース含有溶液を原料糖液とし、これを濃縮して濃
度約45%にした。本糖液のフラクトシルトレハロース
含量を高めるため、分画用樹脂として、塩型強酸性カチ
オン交換樹脂(ダウケミカル社販売、商品名『ダウエッ
クス50W×4』、Ca型)を用いた以外は、実施例A
−4の方法に従ってカラムクロマトグラフィーを行な
い、フラクトシルトレハロース高含有画分を採集した。
更に、精製、濃縮し、真空乾燥し、粉砕して、フラクト
シルトレハロース高含有粉末を固形物収率約20%で得
た。<Example A-11> A solution containing fructosyltrehalose of about 24% based on the solid matter reacted and purified by the method of Example A-9 was used as a raw sugar solution and concentrated to a concentration of about 45%. did. In order to increase the fructosyl trehalose content of the present sugar solution, a salt type strongly acidic cation exchange resin (sold by Dow Chemical Co., trade name “Dowex 50W × 4”, Ca type) was used as a fractionation resin, except that Example A
Column chromatography was carried out in accordance with the method of No. 4 to collect the fructosyltrehalose-rich fraction.
Further, purification, concentration, vacuum drying, and pulverization were performed to obtain powder having a high content of fructosyltrehalose with a solid yield of about 20%.
【0084】本品は、固形物当たり約80%のフラクト
シルトレハロースを含有しており、低い還元性、味質良
好な甘味、保湿性、低う蝕性を有し、甘味剤、呈味改良
剤、安定剤、賦形剤、ビフィズス菌増殖促進剤、ミネラ
ル吸収促進剤などとして飲食物、化粧品、医薬品など各
種組成物に有利に利用できる。This product contains about 80% of fructosyl trehalose per solid matter and has low reducing property, good taste sweetness, moisturizing property and low caries property, and is a sweetener and taste improver. It can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals as an agent, stabilizer, excipient, bifidobacteria growth promoter, mineral absorption promoter and the like.
【0085】〈実施例A−12〉蔗糖を30%及びイソ
マルトース15%を含む糖液をpH5.5に調整し、こ
れに実施例A−1の方法で調製したβ−フラクトフラノ
シダーゼを、蔗糖1グラム当たり0.5単位の割合にな
るように加え、50℃で40時間反応させた。この反応
液を90℃で30分間加熱し、酵素を失活させた後、冷
却し、常法に従って、活性炭で脱色、濾過し、H型及び
OH型イオン交換樹脂により脱塩して精製し、更に濃縮
して、濃度75%のシラップを固形物収率約95%で得
た。Example A-12 A sugar solution containing 30% sucrose and 15% isomaltose was adjusted to pH 5.5, and β-fructofuranosidase prepared by the method of Example A-1 was added thereto. It was added at a ratio of 0.5 unit per gram of sucrose and reacted at 50 ° C. for 40 hours. This reaction solution was heated at 90 ° C. for 30 minutes to inactivate the enzyme, then cooled, decolorized with activated carbon, filtered, desalted and purified with an H-type and OH-type ion exchange resin according to a conventional method, Further concentration gave syrup with a concentration of 75% with a solids yield of about 95%.
【0086】本品は、固形物当たりイソマルトシルフラ
クトシドを約25%含有しており、味質良好な甘味、適
度な糖度、保湿性、低う蝕性を有し、甘味剤、呈味改良
剤、安定剤、ビフィズス菌増殖促進剤、ミネラル吸収促
進剤などとして飲食物、化粧品、医薬品など各種組成物
に有利に利用できる。This product contains about 25% of isomaltosyl fructoside per solid matter, has a good taste sweetness, moderate sugar content, moisturizing property and low cariogenicity, and is a sweetener It can be advantageously used in various compositions such as food and drink, cosmetics and pharmaceuticals as an improving agent, a stabilizer, a bifidobacteria growth promoter, a mineral absorption promoter and the like.
【0087】〈実施例B−1 混合甘味剤〉実施例A−
4の方法で得たラクトスクロース高含有粉末1重量部に
α−グリコシル ステビオシド(東洋精糖株式会社製
造、商品名α−Gスィート)0.05重量部を均一に混
合して粉末甘味料を製造した。本品は、上品な甘味を有
し、砂糖の約2倍の甘味を有する。また、本品は、ビフ
ィズス菌増殖促進効果を発揮し、美容、健康の維持増
進、成人病の予防、病中、病後の回復促進、高アンモニ
ア血症、肝性脳症などの治療、予防などに有利に利用で
きる。また、家畜、家禽などの飼育動物の感染予防、下
痢予防、食欲増進、肥育促進、糞便の臭気抑制などにも
有利に利用できる。Example B-1 Mixed Sweetener Example A-
1 part by weight of the powder having a high content of lactosucrose obtained by the method of 4 was uniformly mixed with 0.05 part by weight of α-glycosyl stevioside (manufactured by Toyo Seika Sugar Co., Ltd., trade name α-G Sweet) to prepare a powder sweetener. . The product has an elegant sweetness, about twice the sweetness of sugar. In addition, this product exerts a bifidobacteria growth-promoting effect and is used for beauty and health maintenance and promotion, prevention of adult diseases, promotion of recovery during and after disease, treatment and prevention of hyperammonemia, hepatic encephalopathy, etc. It can be used to advantage. Further, it can be advantageously used for prevention of infection of domestic animals such as livestock and poultry, prevention of diarrhea, promotion of appetite, promotion of fattening and suppression of odor of feces.
【0088】〈実施例B−2 ハードキャンディー〉還
元麦芽糖水飴(水分25%)80重量部に、実施例A−
12の方法で得たイソマルトシルフラクトシド含有シラ
ップ30重量部を加熱溶解し、減圧下で水分が2%未満
になるまで濃縮し、これにクエン酸1重量部および適量
のレモン香料と着色料とを混和し、次いで、常法に従っ
て成形しハードキャンディーを製造した。<Example B-2 Hard Candy> 80 parts by weight of reduced maltose starch syrup (water content 25%) was added to Example A-2.
30 parts by weight of isomaltosyl fructoside-containing syrup obtained by the method of 12 is dissolved by heating and concentrated under reduced pressure until the water content is less than 2%, and 1 part by weight of citric acid and an appropriate amount of lemon flavor and colorant are added thereto. And were mixed and then molded according to a conventional method to produce a hard candy.
【0089】本品は、上品な甘味を有する低う蝕性のハ
ードキャンディーである。また、本品は、ビフィズス菌
増殖促進効果、ミネラル吸収促進効果を発揮し、美容、
健康の維持増進、成人病の予防、病中、病後の回復促
進、各種疾病の治療、予防などにも有利に利用できる。This product is a low caries hard candy having an elegant sweetness. In addition, this product exerts the effect of promoting the growth of bifidobacteria and the effect of promoting the absorption of minerals.
It can be advantageously used for maintaining and promoting health, preventing adult diseases, promoting recovery during and after illness, and treating and preventing various diseases.
【0090】〈実施例B−3 チューインガム〉ガムベ
ース2重量部を柔らかくなる程度に加熱溶融し、これに
実施例A−4の方法で得たラクトスクロース高含有粉末
4重量部、グルコース3重量部および適量のハッカ香料
と着色料とを混合した後、常法に従ってロールにより練
り合わせ、成形することによってチューインガムを製造
した。Example B-3 Chewing Gum 2 parts by weight of a gum base were melted by heating so as to be soft, and 4 parts by weight of the lactosucrose-rich powder obtained by the method of Example A-4, 3 parts by weight of glucose and After mixing an appropriate amount of mint flavor and color, the mixture was kneaded by a roll according to a conventional method and molded to produce a chewing gum.
【0091】本品は、テクスチャー、甘味ともに良好で
ある。また、本品は、ビフィズス菌増殖促進効果を発揮
し、美容、健康の維持増進、成人病の予防、病中、病後
の回復促進、各種疾病の治療、予防などにも有利に利用
できる。The product has good texture and sweetness. In addition, the product exerts a bifidobacteria growth-promoting effect and can be advantageously used for beauty and health maintenance and promotion, prevention of adult diseases, promotion of recovery during and after illness, and treatment and prevention of various diseases.
【0092】〈実施例B−4 チョコレート〉カカオペ
ースト40重量部、カカオバター10重量部、実施例A
−6の方法で得たエルロース高含有粉末15重量部、蔗
糖10重量部および全脂粉乳15重量部を混合し、レフ
ァイナーを通した。そして粒度を下げた後、コンチェに
入れ、レシチン0.5重量部を加えて、50℃で二昼夜
練り上げた。次いで、常法に従い成型機に流し込み成型
固化して製造した。<Example B-4 Chocolate> 40 parts by weight of cocoa paste, 10 parts by weight of cocoa butter, Example A
15 parts by weight of the erulose-rich powder obtained by the method of -6, 10 parts by weight of sucrose and 15 parts by weight of whole milk powder were mixed and passed through a refiner. After reducing the particle size, the mixture was placed in a conche, to which 0.5 part by weight of lecithin was added, and kneaded at 50 ° C. for two days and nights. Subsequently, it was poured into a molding machine according to a conventional method, and was molded and solidified to be manufactured.
【0093】本品は、ファットブルーム、シュガーブル
ームの恐れがなく、舌にのせた時の融け具合、風味とも
に良好である。This product has no fear of fat bloom or sugar bloom, and has a good melting condition and flavor when placed on the tongue.
【0094】〈実施例B−5 乳飲料〉コーヒー浸出液
70重量部、牛乳100重量部、実施例A−3の方法で
得たラクトスクロース高含有シラップ24重量部および
適量のコーヒー香料、着色料を混合し、均質化した後、
常法に従って、殺菌、冷却、充填、包装して乳飲料を製
造した。<Example B-5 Milk Beverage> 70 parts by weight of coffee brewed liquid, 100 parts by weight of milk, 24 parts by weight of lactosucrose-rich syrup obtained by the method of Example A-3, and an appropriate amount of coffee flavor and colorant were added. After mixing and homogenizing,
A milk drink was produced by sterilization, cooling, filling and packaging according to a conventional method.
【0095】本品は、香り、呈味とも良好なコーヒー牛
乳である。また、本品は、ビフィズス菌増殖促進効果、
ミネラル吸収促進効果を発揮し、美容、健康の維持増
進、成人病の予防、病中、病後の回復促進などに有利に
利用できる。This product is coffee milk having a good scent and taste. In addition, this product has a bifidobacteria growth promoting effect,
It exerts a mineral absorption promoting effect and can be advantageously used for beauty and health maintenance and promotion, prevention of adult diseases, promotion of recovery during and after illness.
【0096】〈実施例B−6 カスタードクリーム〉コ
ーンスターチ500重量部、マルトース(株式会社林原
商事販売、登録商標サンマルト)400重量部および食
塩5重量部を、篩を通して充分に混合し、鶏卵1400
重量部および実施例A−10の方法で得たフラクトシル
トレハロース高含有シラップ600重量部を加えて攪拌
し、これに沸騰した牛乳5000重量部を徐々に加え、
更に、これをとろ火にかけて攪拌を続け、コーンスター
チが完全に糊化して全体が半透明になったときに火を止
め、これを冷却して適量のバニラ香料を加えることによ
りカスタードクリームを製造した。Example B-6 Custard Cream 500 parts by weight of cornstarch, 400 parts by weight of maltose (Hayashibara Shoji Co., Ltd., registered trademark of San Marto) and 5 parts by weight of salt were thoroughly mixed through a sieve to prepare 1400 eggs of chicken.
Parts by weight and 600 parts by weight of syrup having a high content of fructosyl trehalose obtained by the method of Example A-10 were added and stirred, and 5000 parts by weight of boiled milk was gradually added thereto,
Further, this was heated over a simmer to continue stirring, and when the cornstarch was completely gelatinized and the whole became translucent, the heat was turned off, the cornstarch was cooled, and an appropriate amount of vanilla flavor was added to produce a custard cream.
【0097】本品は、なめらかな光沢を有し、甘味が強
すぎず美味である。また、本品は、ビフィズス菌増殖促
進効果を発揮し、美容、健康の維持増進、成人病の予
防、病中、病後の回復促進などに有利に利用できる。This product has a smooth luster and is delicious without being too sweet. In addition, the product exhibits a bifidobacteria growth-promoting effect, and can be advantageously used for beauty and health maintenance and promotion, prevention of adult diseases, and promotion of recovery during and after illness.
【0098】〈実施例B−7 即席コーンポタージュス
ープ〉α−化コーン粉末30重量部、α−化澱粉5重量
部、α−化ポテトスターチ4重量部、α−化ワキシーコ
ーンスターチ12重量部、実施例A−11の方法で得た
フラクトシルトレハロース高含有粉末8重量部、グルタ
ミン酸ナトリウム5重量部、食塩8.5重量部、脱脂粉
乳7重量部、オニオンパウダー0.5重量部を摩砕して
よく混合した後、これにソルビタン脂肪酸エステル0.
5重量部と植物性硬化油9重量部とを加熱融解したもの
を添加して混合し、更に、乳糖10重量部を加えて混合
し、これを流動層造粒機に仕込み、少量の水をスプレー
して造粒した後、70℃の熱風で乾燥し、篩分けして即
席コーンポタージュスープを製造した。Example B-7 Instant Corn Potage Soup> 30 parts by weight of α-modified corn powder, 5 parts by weight of α-modified starch, 4 parts by weight of α-modified potato starch, 12 parts by weight of α-modified waxy cornstarch. Grinding 8 parts by weight of high-fructosyltrehalose-containing powder obtained by the method of Example A-11, 5 parts by weight of sodium glutamate, 8.5 parts by weight of salt, 7 parts by weight of skimmed milk powder, and 0.5 parts by weight of onion powder. After mixing well, add sorbitan fatty acid ester 0.
Heat-melted 5 parts by weight and hydrogenated vegetable oil 9 parts by weight were added and mixed, and further 10 parts by weight of lactose were added and mixed, and this was charged into a fluidized bed granulator, and a small amount of water was added. After spraying and granulating, it was dried with hot air at 70 ° C. and sieved to produce instant corn potage soup.
【0099】本品は、熱湯を注げば、容易に溶解、分散
し、風味の優れたスープとなる。また、本品は、ビフィ
ズス菌増殖促進効果、ミネラル吸収促進効果を発揮し、
美容、健康の維持増進、成人病の予防、病中、病後の回
復促進などに有利に利用できる。This product can be easily dissolved and dispersed by pouring hot water into a soup with an excellent flavor. In addition, this product exerts a bifidobacteria growth promoting effect and mineral absorption promoting effect,
It can be advantageously used for beauty and health maintenance and promotion, prevention of adult diseases, promotion of recovery during and after illness.
【0100】〈実施例B−8 乳液〉ポリオキシエチレ
ンベヘニルエーテル0.5重量部、テトラオレイン酸ポ
リオキシエチレンソルビトール1重量部、親油型モノス
テアリン酸グルセリン1重量部、ベヘニールアルコール
0.5重量部、アボガド油1重量部、実施例A−5の方
法で得たエルロース含有シラップ3.5重量部、α−グ
リコシル ルチン1重量部、ビタミンEおよび防腐剤の
適量を、常法に従って加熱溶解し、これに1,3−ブチ
レングリコール5重量部、カルボキシビニルポリマー
0.1重量部および精製水85.3重量部を加え、ホモ
ゲナイザーにかけ、乳化し、乳液を製造した。Example B-8 Emulsion 0.5 part by weight of polyoxyethylene behenyl ether, 1 part by weight of polyoxyethylene sorbitol tetraoleate, 1 part by weight of lipophilic glyceryl monostearate, behenyl alcohol of 0. 5 parts by weight, avocado oil 1 part by weight, erulose-containing syrup 3.5 parts by weight obtained by the method of Example A-5, 1 part by weight of α-glycosyl rutin, vitamin E and an appropriate amount of preservative were heated according to a conventional method. After dissolution, 5 parts by weight of 1,3-butylene glycol, 0.1 part by weight of carboxyvinyl polymer and 85.3 parts by weight of purified water were added, and the mixture was homogenized and emulsified to prepare an emulsion.
【0101】本品は、保湿性ある乳液で、日焼け止め、
色白剤などとして有利に利用できる。This product is a moisturizing emulsion, which is a sunscreen,
It can be advantageously used as a whitening agent.
【0102】〈実施例B−9 スキンクリーム〉モノス
テアリン酸ポリオキシエチレングリコール2重量部、自
己乳化型モノステアリン酸グリセリン5重量部、α−グ
リコシル ルチン2重量部、流動パラフィン1重量部、
トリオクタン酸グリセリン10重量部、実施例A−9の
方法で得たフラクトシルトレハロース含有シラップ4重
量部および防腐剤の適量を、常法に従って加熱溶解し、
これに1,3−ブチレングリコール5重量部および精製
水66重量部を加え、ホモゲナイザーにかけて乳化し、
更に、香料の適量を加えて攪拌混合し、クリームを製造
した。Example B-9 Skin Cream 2 parts by weight of polyoxyethylene glycol monostearate, 5 parts by weight of self-emulsifying glyceryl monostearate, 2 parts by weight of α-glycosyl rutin, 1 part by weight of liquid paraffin,
10 parts by weight of glyceryl trioctanoate, 4 parts by weight of syrup containing fructosyltrehalose obtained by the method of Example A-9 and an appropriate amount of preservative were dissolved by heating according to a conventional method,
To this, 5 parts by weight of 1,3-butylene glycol and 66 parts by weight of purified water were added and emulsified by applying a homogenizer,
Furthermore, an appropriate amount of flavor was added and mixed with stirring to produce a cream.
【0103】本品は、伸びの良いクリームで、日焼け止
め、美肌剤、色白剤などとして有利に使用できる。This product is a cream with good elongation and can be advantageously used as a sunscreen, skin beautifying agent, skin lightening agent and the like.
【0104】〈実施例B−10 練歯磨〉第二リン酸カ
ルシウム45重量部、ラウリル硫酸ナトリウム1.5重
量部、グリセリン25重量部、ポオキシエチレンソルビ
タンラウレート0.5重量部、実施例A−8の方法で得
たキシロシルフラクトシド高含有シラップ15重量部、
サッカリン0.02重量部および防腐剤0.05重量部
を水13重量部と混合して練歯磨を得た。Example B-10 Toothpaste 45 parts by weight of dibasic calcium phosphate, 1.5 parts by weight of sodium lauryl sulfate, 25 parts by weight of glycerin, 0.5 parts by weight of pooxyethylene sorbitan laurate, Example A-8. 15 parts by weight of xylopyl fructoside-rich syrup obtained by the method of
0.02 parts by weight of saccharin and 0.05 part by weight of a preservative were mixed with 13 parts by weight of water to obtain a toothpaste.
【0105】本品は、光沢、洗浄力も良好で、練歯磨と
して好適である。The product has good gloss and detergency and is suitable as a toothpaste.
【0106】〈実施例B−11 経管栄養剤〉実施例A
−6の方法で得たエルロース高含有粉末20重量部、グ
リシン1.1重量部、グルタミン酸ナトリウム1重量
部、乳酸カルシウム0.4重量部、炭酸マグネシウム
0.1重量部、チアミン0.01重量部およびリボフラ
ビン0.01重量部からなる配合物を調製する。この配
合物24gずつをラミネートアルミ製小包に充填し、ヒ
ートシールして製品を得た。Example B-11 Tube Feeding Agent Example A
20 parts by weight of powder containing a high amount of erulose obtained by the method of No. 6, 1.1 parts by weight of glycine, 1 part by weight of sodium glutamate, 0.4 part by weight of calcium lactate, 0.1 part by weight of magnesium carbonate, 0.01 part by weight of thiamine. And 0.01 parts by weight of riboflavin are prepared. Each 24 g of this mixture was filled in a laminated aluminum package and heat-sealed to obtain a product.
【0107】本品は、1袋分を約300乃至500ml
の水に溶解して栄養補給液とし、経管方法により、鼻
腔、胃腸などへ投与して使用する。This product contains about 300 to 500 ml per bag.
It is used as a nutritional supplement by dissolving it in water and administering it to the nasal cavity, gastrointestinal tract, etc. by the tube method.
【0108】本品は、ヒトのみならず、家畜などへの非
経口的栄養補給液としても有利に利用できる。This product can be advantageously used as a parenteral nutritional supplement liquid for domestic animals as well as humans.
【0109】〈実施例B−12 経管栄養剤〉実施例A
−4の方法で得たラクトスクロース高含有粉末580重
量部、乾燥卵黄190重量部、脱脂粉乳209重量部、
塩化ナトリウム4.4重量部、塩化カリウム1.85重
量部、硫酸マグネシウム4重量部、チアミン0.01重
量部、アスコルビン酸ナトリウム0.1重量部、ビタミ
ンEアセテート0.6重量部およびニコチン酸アミド
0.04重量部からなる配合物を調製する。この配合物
25gずつを、ラミネートアルミ製小袋に充填し、ヒー
トシールして、個体状経管栄養剤を製造した。Example B-12 Tube Feeding Agent Example A
580 parts by weight of lactosucrose-rich powder obtained by the method of No. 4, 190 parts by weight of dried egg yolk, 209 parts by weight of skim milk powder,
Sodium chloride 4.4 parts by weight, potassium chloride 1.85 parts by weight, magnesium sulfate 4 parts by weight, thiamine 0.01 parts by weight, sodium ascorbate 0.1 parts by weight, vitamin E acetate 0.6 parts by weight and nicotinic acid amide. A formulation consisting of 0.04 parts by weight is prepared. Each 25 g of this mixture was filled in a laminated aluminum pouch and heat-sealed to produce a solid tube feeding agent.
【0110】本品は、長期間品質が安定して維持され、
溶解性、分散性が良好である。本剤は、1袋分を約15
0乃至300mlの水に溶解して栄養補給液とし、経管
方法により、鼻腔、食道、胃などへ投与して利用する。
また、本品は、ビフィズス菌増殖促進効果、ミネラル吸
収促進効果を発揮し、美容、健康の維持増進、成人病の
予防、病中、病後の回復促進、各種疾病の治療、予防、
更には、家畜、家禽などの病中、病後の回復促進、肥育
促進などに有利に利用できる。This product maintains stable quality for a long time,
Good solubility and dispersibility. This drug can be used for about 15 bags.
It is dissolved in 0 to 300 ml of water to prepare a nutritional supplement liquid, which is administered to the nasal cavity, esophagus, stomach, etc. by a tube method for use.
In addition, this product exerts the effect of promoting the growth of bifidobacteria and the effect of promoting the absorption of minerals, and improves the maintenance of beauty and health, the prevention of adult diseases, the promotion of recovery during and after illness, the treatment and prevention of various diseases,
Further, it can be advantageously used for promoting recovery after and after illness of livestock, poultry and the like, and promoting fattening.
【0111】〈実施例B−13 錠剤〉実施例A−11
の方法で得たフラクトシルトレハロース高含有粉末40
重量部、マルトース10重量部、第三リン酸カルシウム
1重量部、シュガーエステル1重量部および適量の粉末
香料を均一に混合した後、常法に従って、1錠約350
mgになるように打錠機にて打錠し、錠剤を得た。Example B-13 Tablets Example A-11
Fructosyltrehalose-rich powder 40 obtained by the method
1 part by weight, maltose 10 parts by weight, tricalcium phosphate 1 part by weight, sugar ester 1 part by weight and an appropriate amount of powdered flavor are uniformly mixed, and then, in accordance with a conventional method, 1 tablet approximately 350
Tablets were obtained by tableting with a tableting machine so as to give mg.
【0112】本品は、ひび割れもなく安定性良好な飲み
やすい錠剤で、成人1日当たり、約1乃至40錠、望ま
しくは、約2乃至20錠摂取することにより、ビフィズ
ス菌増殖促進効果、ミネラル吸収促進効果を発揮し、美
容、健康の維持増進、成人病の予防、病中、病後の回復
促進、各種疾病の治療、予防などに有利に利用できる。This product is an easy-to-drink tablet with no cracks and good stability. It is taken by an adult for about 1 to 40 tablets, preferably about 2 to 20 tablets, and it has a bifidobacteria growth promoting effect and mineral absorption. It exerts a promoting effect and can be advantageously used for beauty and health maintenance and promotion, prevention of adult diseases, promotion of recovery during and after illness, and treatment and prevention of various diseases.
【0113】〈実施例B−14 インターフェロン錠
剤〉ヒト天然型インターフェロン−α標品(株式会社林
原生物化学研究所製造、コスモ・バイオ株式会社販売)
を、常法に従って、固定化抗ヒトインターフェロン−α
抗体カラムにかけ、該標品に含まれるヒト天然型インタ
ーフェロン−αを吸着させ、安定剤である牛血清アルブ
ミンを素通りさせて除去し、次いで、pHを変化させ
て、ヒト天然型インターフェロン−αを実施例A−4の
方法で得たラクトスクロース高含有粉末を5%含有する
生理食塩水を用いて溶出した。本液を精密濾過し、約2
0倍量の無水結晶マルトース粉末(株式会社林原商事販
売、商品名『ファイントース(登録商標)』)に加えて
脱水、粉末化し、これを打錠機にて打錠し、1錠(約2
00mg)当たりヒト天然型インターフェロン−αを約
150単位含有する錠剤を得た。<Example B-14 Interferon tablet> Human natural interferon-α preparation (manufactured by Hayashibara Biochemical Laboratory Co., Ltd., sold by Cosmo Bio Co., Ltd.)
The immobilized anti-human interferon-α was
Apply the antibody to an antibody column, adsorb the human natural interferon-α contained in the sample, remove the stabilizer bovine serum albumin by passing it through, and then change the pH to carry out human natural interferon-α. The lactosucrose-rich powder obtained by the method of Example A-4 was eluted with physiological saline containing 5%. This solution is microfiltered to give about 2
Dehydrated and powdered with 0 times the amount of anhydrous crystalline maltose powder (trade name "Fine Tose (registered trademark)" sold by Hayashibara Shoji Co., Ltd.), and tableted with a tableting machine to give 1 tablet (about 2 tablets).
A tablet containing about 150 units of human natural interferon-α per (00 mg) was obtained.
【0114】本品は、舌下錠などとして、1日当たり、
大人1乃至10錠程度が経口的に投与され、ウイルス性
疾患、アレルギー性疾患、リューマチ、糖尿病、悪性腫
瘍などの治療に有利に利用できる。とりわけ、近年、患
者数の急増しているエイズ、肝炎などの治療剤として有
利に利用できる。本品は、ラクトスクロースと共にマル
トースが安定剤として作用し、室温で放置してもその活
性を長期間よく維持する。This product is used as a sublingual tablet, etc.
About 1 to 10 tablets for adults are orally administered and can be advantageously used for treatment of viral diseases, allergic diseases, rheumatism, diabetes, malignant tumors and the like. In particular, it can be advantageously used as a therapeutic agent for AIDS, hepatitis, etc., for which the number of patients is increasing rapidly in recent years. In this product, maltose acts as a stabilizer together with lactosucrose, and maintains its activity for a long period of time even when left at room temperature.
【0115】〈実施例B−15 配合飼料〉粉麩40重
量部、脱脂粉乳38重量部、実施例A−11の方法で得
たフラクトシルトレハロース高含有粉末12重量部、ビ
タミン剤10重量部、魚粉5重量部、第二リン酸カルシ
ウム5重量部、液状油脂3重量部、炭酸カルシウム3重
量部、食塩2重量部およびミネラル剤2重量部を配合し
て、配合飼料を製造した。Example B-15 Compounded feed 40 parts by weight of flour, 38 parts by weight of skimmed milk powder, 12 parts by weight of powder containing high fructosyltrehalose obtained by the method of Example A-11, 10 parts by weight of vitamin preparation, 5 parts by weight of fish meal, 5 parts by weight of dibasic calcium phosphate, 3 parts by weight of liquid oil and fat, 3 parts by weight of calcium carbonate, 2 parts by weight of salt and 2 parts by weight of mineral agent were mixed to produce a compounded feed.
【0116】本品は、嗜好性の向上した家畜、家禽など
の飼料であって、とりわけ、子豚用飼料として好適であ
る。また、本品はビフィズス菌増殖効果、ミネラル吸収
促進効果を発揮し、飼育動物の感染予防、下痢予防、食
欲増進、肥育促進、糞便の臭気抑制などに有利に利用で
きる。更に、本品は、必要に応じて、他の飼料材料、例
えば、穀類、小麦粉、澱粉、油粕類、糟糠類などの濃厚
飼料材料や、ワラ、乾草、バガス、コーンコブなどの粗
飼料材料などと併用して、他の配合飼料にすることもで
きる。The product is a feed for domestic animals, poultry and the like with improved palatability, and is particularly suitable as a feed for piglets. In addition, this product exerts a bifidobacteria-proliferating effect and a mineral absorption promoting effect, and can be advantageously used for prevention of infection of domestic animals, prevention of diarrhea, promotion of appetite, promotion of fattening, suppression of odor of feces, and the like. In addition, this product is used, if necessary, in combination with other feed ingredients, for example, concentrated feed ingredients such as grains, wheat flour, starch, oil meal and rice bran, and roughage ingredients such as straw, hay, bagasse and corn cob. Then, other mixed feed can be used.
【0117】[0117]
【発明の効果】以上述べたように、本発明は、工業的実
施に有利なフラクトシル転移能の高い微生物由来の新規
β−フラクトフラノシダーゼとその製造方法並びに用途
に関する。本発明のβ−フラクトフラノシダーゼを、蔗
糖を供与体とし、還元性又は非還元性の糖質を受容体と
して作用させると、受容体にフラクトシル基を転移して
非還元性糖質を生成する。新たに生成したフラクトシル
転移糖は、味質良好な甘味を有し、また浸透圧調節性、
保湿性、照付与性、結晶防止性、澱粉老化防止性などの
性質を有し、更には、抗う蝕性、ビフィズス菌増殖促進
性、ミネラル吸収促進性などの機能をも有し、広く、飲
食物、化粧品、医薬品、成形物など各種組成物に有利に
利用される。従って、食品、化粧品、医薬品などの分野
における工業的意義はきわめて大きい。INDUSTRIAL APPLICABILITY As described above, the present invention relates to a novel β-fructofuranosidase derived from a microorganism having a high fructosyl transfer ability, which is advantageous in industrial practice, a method for producing the same and use thereof. When β-fructofuranosidase of the present invention is used with sucrose as a donor and a reducing or non-reducing sugar as an acceptor, a fructosyl group is transferred to the acceptor to produce a non-reducing sugar. . The newly produced fructosyl-transferred sugar has a good taste and sweetness, and also has an osmotic pressure regulating property,
It has properties such as moisturizing properties, light-imparting properties, anti-crystallization properties, and starch anti-aging properties, and also has functions such as caries resistance, bifidobacteria growth-promoting properties, and mineral absorption-promoting properties. It is advantageously used for various compositions such as products, cosmetics, pharmaceuticals and molded products. Therefore, the industrial significance in the fields of food, cosmetics, pharmaceuticals, etc. is extremely great.
【図1】 本発明のβ−フラクトフラノシダーゼ活性に
及ぼすpHの影響を示す図である。FIG. 1 is a graph showing the effect of pH on β-fructofuranosidase activity of the present invention.
【図2】 本発明のβ−フラクトフラノシダーゼ活性に
及ぼす温度の影響を示す図である。FIG. 2 is a graph showing the effect of temperature on the β-fructofuranosidase activity of the present invention.
【図3】 本発明のβ−フラクトフラノシダーゼのpH
安定性を示す図である。FIG. 3 pH of β-fructofuranosidase of the present invention
It is a figure which shows stability.
【図4】 本発明のβ−フラクトフラノシダーゼの熱安
定性を示す図である。FIG. 4 is a diagram showing the thermostability of β-fructofuranosidase of the present invention.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A23K 1/16 303 A23K 1/16 303D A23L 1/236 A23L 1/236 A 1/30 1/30 Z 1/40 1/40 2/38 2/38 P A61K 9/20 ACK A61K 9/20 ACKA C12P 19/18 C12P 19/18 // A61K 7/00 A61K 7/00 F 7/16 7/16 7/48 7/48 31/70 ADD 31/70 ADD AER AER (C12N 9/24 C12R 1:07) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location A23K 1/16 303 A23K 1/16 303D A23L 1/236 A23L 1/236 A 1/30 1/30 Z 1/40 1/40 2/38 2/38 P A61K 9/20 ACK A61K 9/20 ACKA C12P 19/18 C12P 19/18 // A61K 7/00 A61K 7/00 F 7/16 7/16 7 / 48 7/48 31/70 ADD 31/70 ADD AER AER (C12N 9/24 C12R 1:07)
Claims (13)
トフラノシダーゼ。 (1) 作用 少なくとも蔗糖、ラフィノース及びエルロースのβ−フ
ラクトフラノシド結合を加水分解して、フラクトースを
遊離する。また、これらβ−フラクトフラノシド結合を
有する糖質を糖供与体として、糖供与体以外の他の糖
質、糖アルコール及びアルコール類から選ばれる受容体
にβ−フラクトフラノシル基の転移を触媒する。 (2) 分子量 SDS−ゲル電気泳動法で、49,000±5,000
ダルトン (3) 等電点 アンフォライン含有電気泳動法で、4.6±0.5 (4) 至適pH 40℃、10分間反応で、約5.5乃至6.0 (5) 至適温度 pH6.0、10分間反応で、カルシウムイオン非存在
下で45℃付近,カルシウムイオン存在下で50℃付近 (6) pH安定性 温度4℃、24時間保持の条件で、pH約5.0乃至
8.0の範囲で安定 (7) 温度安定性 pH6.0、1時間保持の条件で、45℃付近まで安定1. A β-fructofuranosidase having the following physicochemical properties. (1) Action Hydrolyzes at least β-fructofuranoside bonds of sucrose, raffinose and erulose to release fructose. In addition, the sugar having these β-fructofuranoside bonds is used as a sugar donor, and the transfer of the β-fructofuranosyl group is catalyzed to an acceptor selected from sugars other than sugar donors, sugar alcohols and alcohols. To do. (2) Molecular weight By SDS-gel electrophoresis, 49,000 ± 5,000.
Dalton (3) By isoelectric focusing ampholine-containing electrophoresis method, 4.6 ± 0.5 (4) Optimum pH 40 ° C., 10 minutes reaction, about 5.5 to 6.0 (5) Optimum temperature At pH 6.0 for 10 minutes, around 45 ° C in the absence of calcium ions, around 50 ° C in the presence of calcium ions (6) pH stability At a temperature of 4 ° C for 24 hours, pH of about 5.0 to 5.0 Stable in the range of 8.0 (7) Temperature stability Stable up to around 45 ° C under the condition of pH 6.0 and holding for 1 hour
1記載のβ−フラクトフラノシダーゼ。2. The β-fructofuranosidase according to claim 1, which is derived from a microorganism belonging to the genus Bacillus.
0(工業技術院生命工学工業技術研究所、受託番号 F
ERM BP−5054)である請求項2記載のβ−フ
ラクトフラノシダーゼ。3. The microorganism is Bacillus species V23.
0 (Institute of Biotechnology, Institute of Biotechnology, Contract No. F)
ERM BP-5054), The β-fructofuranosidase according to claim 2.
する微生物を培養し、培養物から請求項1、2又は3記
載のβ−フラクトフラノシダーゼを採取することを特徴
とするβ−フラクトフラノシダーゼの製造方法。4. A β-fructofuranosidase characterized by comprising culturing a microorganism capable of producing β-fructofuranosidase, and collecting the β-fructofuranosidase according to claim 1, 2 or 3 from the culture. Production method.
する微生物が、バチルス・スピーシーズに属する微生物
である請求項4記載のβ−フラクトフラノシダーゼの製
造方法。5. The method for producing β-fructofuranosidase according to claim 4, wherein the microorganism capable of producing β-fructofuranosidase is a microorganism belonging to Bacillus species.
する微生物バチルス・スピーシーズV230(工業技術
院生命工学工業技術研究所、受託番号 FERM BP
−5054)。6. A microorganism having an ability to produce β-fructofuranosidase, Bacillus species V230 (Institute of Biotechnology, Institute of Industrial Science, Accession No. FERM BP)
-5054).
に、請求項1、2又は3記載のβ−フラクトフラノシダ
ーゼを作用させ得られるフラクトシル転移糖含有糖質。7. A fructosyl transfer sugar-containing saccharide obtainable by allowing the β-fructofuranosidase according to claim 1, 2 or 3 to act on a solution containing sucrose and other saccharides.
クトシド、エルロース、イソマルトシルフラクトシド、
ラクトスクロース及びフラクトシルトレハロースから選
ばれる糖質である請求項7記載のフラクトシル転移糖含
有糖質。8. The fructosyl-transferred sugar is xylosyl fructoside, erulose, isomaltosyl fructoside,
The fructosyl transfer sugar-containing saccharide according to claim 7, which is a saccharide selected from lactosucrose and fructosyltrehalose.
クロマトグラフィーから選ばれる方法によりフラクトシ
ル転移糖の含量を高めた請求項7又は8記載のフラクト
シル転移糖含有糖質。9. The fructosyl transfer sugar-containing sugar according to claim 7, wherein the content of the fructosyl transfer sugar is increased by a method selected from a yeast fermentation method, an alkali treatment method and a column chromatography.
ル転移糖含有糖質を含有せしめた組成物。10. A composition containing the fructosyl-transferring saccharide-containing saccharide according to claim 7, 8, or 9.
は成形物であることを特徴とする請求項10記載の組成
物。11. The composition according to claim 10, which is a food or drink, a cosmetic, a pharmaceutical product, or a molded product.
液に、請求項1、2又は3記載のβ−フラクトフラノシ
ダーゼを作用させるフラクトシル転移糖含有糖質の製造
方法。12. A method for producing a saccharide containing a fructosyl-transferred sugar, which comprises reacting a solution containing sucrose and a saccharide other than sucrose with β-fructofuranosidase according to claim 1, 2 or 3.
ス、キシロース、トレハロース、イソマルトース、ガラ
クトース、セロビオース、パノース、メリビオースから
選ばれる1種もしくは2種以上である請求項12記載の
フラクトシル転移糖含有糖質の製造方法。13. The fructosyl transfer sugar-containing saccharide according to claim 12, wherein the other sugar is one or more selected from lactose, maltose, xylose, trehalose, isomaltose, galactose, cellobiose, panose and melibiose. Method for producing sugar.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35378096A JP3761270B2 (en) | 1995-12-18 | 1996-12-18 | β-Fructofuranosidase, production method and use thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7-347543 | 1995-12-18 | ||
JP34754395 | 1995-12-18 | ||
JP35378096A JP3761270B2 (en) | 1995-12-18 | 1996-12-18 | β-Fructofuranosidase, production method and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09224665A true JPH09224665A (en) | 1997-09-02 |
JP3761270B2 JP3761270B2 (en) | 2006-03-29 |
Family
ID=26578532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35378096A Expired - Lifetime JP3761270B2 (en) | 1995-12-18 | 1996-12-18 | β-Fructofuranosidase, production method and use thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3761270B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002065293A (en) * | 2000-08-30 | 2002-03-05 | Hayashibara Biochem Lab Inc | Transfer method of glucosyl group to polyalcohol |
JP2007031413A (en) * | 2005-06-21 | 2007-02-08 | Okuno Chem Ind Co Ltd | Vitamin preparation |
JPWO2005103276A1 (en) * | 2004-04-22 | 2008-03-13 | 株式会社林原生物化学研究所 | Lactosucrose-rich carbohydrate, production method and use thereof |
JP2009082070A (en) * | 2007-09-28 | 2009-04-23 | Hayashibara Biochem Lab Inc | Taste and / or umami enhancement method from salt of food and drink |
JP2009171870A (en) * | 2008-01-22 | 2009-08-06 | Nagase & Co Ltd | Trypsin-like enzyme |
WO2009133835A1 (en) | 2008-05-02 | 2009-11-05 | 株式会社林原生物化学研究所 | METHOD OF INHIBITING COLORING OF A SYRUP-LIKE SWEETENER CONTAINING A NON-REDUCING OLIGOSACCHARIDE HAVING A β-FRUCTOFURANOSIDE BOND AND A REDUCING SUGAR, AND USE THEREOF |
JP2012085561A (en) * | 2010-10-18 | 2012-05-10 | Ohkawara Kakohki Co Ltd | Method for producing potage soup powder |
JP2012193181A (en) * | 2005-06-21 | 2012-10-11 | Okuno Chemical Industries Co Ltd | Vitamin preparation |
JP2021520189A (en) * | 2018-04-04 | 2021-08-19 | オプティバイオティクス リミテッド | Prebiotic composition and its production method |
WO2024154813A1 (en) * | 2023-01-20 | 2024-07-25 | 京都府公立大学法人 | Fructosylated maltitol, and method for producing same |
-
1996
- 1996-12-18 JP JP35378096A patent/JP3761270B2/en not_active Expired - Lifetime
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002065293A (en) * | 2000-08-30 | 2002-03-05 | Hayashibara Biochem Lab Inc | Transfer method of glucosyl group to polyalcohol |
JPWO2005103276A1 (en) * | 2004-04-22 | 2008-03-13 | 株式会社林原生物化学研究所 | Lactosucrose-rich carbohydrate, production method and use thereof |
JP2007031413A (en) * | 2005-06-21 | 2007-02-08 | Okuno Chem Ind Co Ltd | Vitamin preparation |
JP2012193181A (en) * | 2005-06-21 | 2012-10-11 | Okuno Chemical Industries Co Ltd | Vitamin preparation |
JP2009082070A (en) * | 2007-09-28 | 2009-04-23 | Hayashibara Biochem Lab Inc | Taste and / or umami enhancement method from salt of food and drink |
JP2009171870A (en) * | 2008-01-22 | 2009-08-06 | Nagase & Co Ltd | Trypsin-like enzyme |
JPWO2009133835A1 (en) * | 2008-05-02 | 2011-09-01 | 株式会社林原生物化学研究所 | Method for inhibiting coloring of syrup-like sweetener containing non-reducing oligosaccharide having β-fructofuranoside bond and reducing sugar and use thereof |
WO2009133835A1 (en) | 2008-05-02 | 2009-11-05 | 株式会社林原生物化学研究所 | METHOD OF INHIBITING COLORING OF A SYRUP-LIKE SWEETENER CONTAINING A NON-REDUCING OLIGOSACCHARIDE HAVING A β-FRUCTOFURANOSIDE BOND AND A REDUCING SUGAR, AND USE THEREOF |
JP5309404B2 (en) * | 2008-05-02 | 2013-10-09 | 株式会社林原 | Method for inhibiting coloring of syrup-like sweetener containing non-reducing oligosaccharide having β-fructofuranoside bond and reducing sugar and use thereof |
US9215887B2 (en) | 2008-05-02 | 2015-12-22 | Hayashibara Co., Ltd. | Method for inhibiting coloring of a syrupy sweetener comprising a non-reducing oligosaccharide having a beta-fructofranosidic linkage and a reducing saccharide, and use thereof |
JP2012085561A (en) * | 2010-10-18 | 2012-05-10 | Ohkawara Kakohki Co Ltd | Method for producing potage soup powder |
JP2021520189A (en) * | 2018-04-04 | 2021-08-19 | オプティバイオティクス リミテッド | Prebiotic composition and its production method |
US12042506B2 (en) | 2018-04-04 | 2024-07-23 | Optibiotix Limited | Prebiotic compositions and methods of production thereof |
WO2024154813A1 (en) * | 2023-01-20 | 2024-07-25 | 京都府公立大学法人 | Fructosylated maltitol, and method for producing same |
Also Published As
Publication number | Publication date |
---|---|
JP3761270B2 (en) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3633648B2 (en) | Maltose / trehalose converting enzyme, its production method and use | |
KR100394149B1 (en) | Trehalose and its production and use | |
JP4560104B2 (en) | Non-reducing saccharide-forming enzyme, its production method and use | |
KR100306868B1 (en) | Trehalose Free Enzyme and Manufacturing Method and Uses | |
KR100334056B1 (en) | Non-reducing oligosaccharides and preparation methods and uses | |
KR100371670B1 (en) | Maltohexaose and maltoheptaose-producing amylase and its preparation method and uses | |
KR100391376B1 (en) | Thermostable trehalose-releasing enzyme, and its preparation and uses | |
JP3793590B2 (en) | Non-reducing saccharides, production method and use thereof | |
WO2002057011A1 (en) | Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method | |
KR100545108B1 (en) | β-fructofuranosidase, preparation method and use thereof | |
KR100379784B1 (en) | Non-reducing saccharide and its production and use | |
JP3761270B2 (en) | β-Fructofuranosidase, production method and use thereof | |
JP3616166B2 (en) | Trehalose and its production method and use | |
KR100350845B1 (en) | Crystalline maltosyl glucoside, its preparation method and the food containing it | |
JP3967437B2 (en) | Trehalose phosphorylase, its production method and use | |
JP3963491B2 (en) | Crystalline maltosyl glucoside, its production method and use | |
US5908767A (en) | Non-reducing saccharide and its production and use | |
JPH09313117A (en) | Glucide containing trehalose, its production and use | |
JP4171761B2 (en) | Kojibiose phosphorylase, its production method and use | |
JP3725148B2 (en) | Maltose / trehalose converting enzyme, its production method and use | |
JP2004211097A (en) | Maltohexaose-maltoheptaose-forming amylase, production method and use thereof | |
JP2004081221A (en) | Trehalose releasing enzyme, its production method and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050614 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050811 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051011 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051125 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060104 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060110 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130120 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130120 Year of fee payment: 7 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140120 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |